rfhg_240532.1

Basic information about the TSS

---

TSS ID: rfhg_240532.1 TSS ID(Version3): hg_201010.1 hg_201009.1 Species: human Chr: chrX		Start: 154374593 End: 154374643 Strand: -
Source datasets	FANTOM5|EPD|DRA000914|ENCODE|RAMPAGE|PRJNA615891|PRJDB5282 |PRJNA4843412|DRA013844
Protocol	CAGE|TSS_database|RAMPAGE|SLIC_CAGE|C1CAGE|NETCAGE
TSS cluster detected*	9

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D4322433,EH38E2774230)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000369850.10:0 GU727643:0 AK125630:0 GeneID: 2316 HGNC/MGI_ID: HGNC:3754 UniProt_ID: P21333 Nearer transcript ids and distances:

Gene_name: FLNA Gene_symbol: FLNA Gene_synonyms: ABP-280 Gene_source: HGNC:3754

TATA-Box annotation

---

Distance to TSS:	16
Nearest PromoterID:	NM_001110556
Entrez ID:	2316
Nearest Unigene:	Hs.195464
Nearest Refseq:	NM_001456
Nearest Ensembl:	ENSG00000196924
Gene Name:	FLNA
Gene Alias:	ABP-280|ABPX|CSBS|CVD1|FGS2|FLN|FLN-A|FLN1|FMD|MNS|NHBP|OPD|OPD1|OPD2|XLVD|XMVD
Gene Type:	protein-coding
CpG%:	0.200000
GC%:	0.745098
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@FLNA p2@FLNA p3@FLNA p4@FLNA p5@FLNA p6@FLNA p7@FLNA p8@FLNA
Sample		p1@FLNA	p2@FLNA	p3@FLNA	p4@FLNA	p5@FLNA	p6@FLNA	p7@FLNA	p8@FLNA
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	136.36	25.52	20.45	2.73	1.95	0.78	0.58	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	143.65	24.48	21.45	1.42	1.42	0.20	1.21	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	136.58	29.71	18.33	1.16	1.74	0.39	0.39	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	127.66	16.84	10.81	0.00	1.25	0.21	0.21	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	128.46	23.40	8.32	1.35	0.67	0.67	0.45	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	123.46	23.45	7.36	1.36	0.97	0.00	0.39	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	133.78	22.01	8.28	2.61	1.53	0.65	0.65	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	131.53	23.74	8.96	1.21	1.45	0.24	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	140.63	19.45	8.76	1.28	1.07	0.64	0.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	99.70	13.33	2.32	0.58	1.74	0.00	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	93.38	10.91	3.64	0.81	0.81	0.00	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	89.04	11.79	3.25	0.81	1.22	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	441.02	207.78	261.13	44.01	7.25	3.06	2.26	2.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	403.09	187.34	177.11	35.63	8.12	1.80	1.95	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	418.25	189.04	220.21	38.42	7.03	1.76	1.54	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	387.80	200.19	195.66	38.48	8.05	3.77	2.26	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	364.08	187.17	193.07	28.83	3.93	3.28	3.49	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	364.45	196.57	191.08	27.00	10.12	3.37	2.53	5.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	399.33	202.07	179.14	24.53	8.53	2.13	3.20	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	403.33	166.09	187.45	33.40	8.58	1.50	1.65	2.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	441.18	186.71	206.09	37.69	9.36	1.87	2.27	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	413.95	181.60	182.29	32.28	8.63	2.24	2.93	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	435.21	194.40	192.21	34.77	6.20	2.59	2.46	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	368.37	178.60	202.38	40.53	8.74	1.70	1.46	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	363.51	198.14	221.87	43.08	4.90	1.29	2.58	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	399.44	198.77	191.81	27.22	5.38	1.27	0.95	3.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	382.97	218.68	167.04	21.98	7.14	1.10	1.10	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	555.43	218.78	242.35	37.48	9.19	2.12	4.01	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	389.76	169.92	168.31	32.14	6.14	1.29	1.45	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	418.03	166.67	199.24	36.37	5.97	1.81	1.99	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	384.15	166.22	186.32	27.63	7.12	1.47	2.09	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	372.20	163.93	186.78	31.07	6.25	2.54	0.98	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	415.09	194.78	178.53	28.07	7.17	2.95	1.27	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	427.36	184.07	109.68	22.43	8.58	2.64	3.13	2.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	384.64	157.45	178.20	36.84	7.11	3.93	3.18	3.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	374.82	161.92	200.63	33.15	6.32	1.72	2.11	2.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	364.41	160.85	169.43	31.47	8.18	2.66	1.23	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	412.65	159.78	166.43	32.84	7.86	0.81	2.22	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	471.33	163.14	168.27	29.17	8.10	3.51	2.70	3.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	423.23	156.76	185.81	24.73	5.76	2.40	1.92	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	383.24	141.63	165.86	27.53	4.71	2.35	1.18	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	403.46	171.72	112.72	22.98	6.88	2.20	2.34	2.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	370.12	154.80	190.65	33.74	7.80	1.90	2.74	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	385.14	168.71	203.15	32.34	7.34	1.40	2.45	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	486.67	153.39	198.56	34.53	6.42	2.21	3.01	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	439.24	148.43	189.61	32.57	9.54	2.33	3.02	2.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	384.81	178.49	207.76	31.91	3.84	2.16	1.68	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	438.13	151.41	170.19	30.10	4.17	2.68	1.19	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	393.77	176.18	203.71	36.86	5.03	1.68	3.35	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	421.18	166.61	174.70	31.74	4.45	1.21	1.42	2.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	466.06	177.69	163.55	32.38	8.61	5.12	2.46	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	520.80	205.25	250.17	46.25	12.68	2.00	2.22	2.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	293.84	69.96	69.96	0.00	0.00	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	497.87	202.62	215.04	41.52	9.23	3.55	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	505.69	203.14	214.74	35.13	10.27	2.32	1.66	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	381.72	98.16	47.82	10.07	6.71	6.71	5.87	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	478.99	153.85	84.50	16.07	8.27	4.59	3.21	4.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	461.85	212.29	205.16	40.19	10.37	3.57	3.24	2.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	434.22	198.16	229.64	51.07	6.74	1.28	1.61	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	526.50	169.11	111.90	24.83	11.94	5.03	3.46	3.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	418.80	229.85	246.06	58.52	8.46	0.71	2.12	3.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	404.89	234.41	219.83	47.67	12.34	2.24	0.56	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	426.73	181.52	99.52	33.44	10.35	9.55	3.98	16.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	427.09	221.53	160.71	46.89	8.15	3.40	3.06	2.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	402.25	295.35	373.98	67.26	9.10	0.65	2.92	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	368.47	348.59	469.28	89.10	12.78	5.68	3.90	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	177.80	96.98	16.16	32.33	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	323.80	134.26	94.77	7.90	7.90	23.69	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	371.49	416.83	501.17	61.91	18.53	2.93	4.88	3.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	402.65	369.42	435.87	58.51	11.90	0.99	1.98	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	388.43	385.61	362.63	73.65	8.44	2.35	2.35	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	447.10	229.18	169.24	34.77	8.61	2.32	2.65	3.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	340.58	272.22	232.62	41.76	13.92	2.17	3.71	4.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	380.04	279.45	281.90	40.36	7.95	2.45	1.53	2.45
Adipocyte - breast, donor1	11376-118A8	604.71	328.01	105.01	24.87	4.91	3.33	2.06	0.48
Adipocyte - breast, donor2	11327-117E4	471.01	264.22	133.96	29.36	11.39	9.14	2.73	4.33
Adipocyte - omental, donor1	11473-119C6	639.45	453.95	339.06	51.40	6.62	2.54	1.40	1.27
Adipocyte - omental, donor2	11474-119C7	477.65	373.00	229.48	35.13	11.21	8.22	2.24	2.99
Adipocyte - omental, donor3	11475-119C8	395.54	303.44	448.79	47.56	6.70	4.35	2.01	1.34
Adipocyte - perirenal, donor1	11476-119C9	318.36	322.82	236.06	37.00	8.29	5.74	2.55	4.47
Adipocyte - subcutaneous, donor1	11259-116F8	147.33	122.05	237.49	26.39	0.00	1.10	1.10	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	290.39	56.90	7.23	2.26	0.90	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	115.73	17.73	2.09	0.35	0.52	0.17	0.00	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	314.48	108.35	97.00	17.21	1.37	0.20	0.98	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	279.77	74.64	21.88	5.92	2.32	0.51	0.77	2.32
Adipocyte differentiation, day04, donor3	13025-139E1	353.76	112.90	30.66	5.02	1.39	0.28	0.56	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	234.54	29.98	11.76	2.35	0.59	0.00	0.00	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	128.93	22.68	6.84	1.37	0.24	0.16	0.00	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	233.67	35.18	7.10	1.61	1.61	0.32	0.00	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	194.08	44.25	14.40	4.80	6.40	0.53	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	174.72	23.37	2.78	1.11	1.67	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	107.72	21.21	16.64	1.66	0.42	0.00	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	181.59	35.16	3.52	1.76	1.00	0.75	0.25	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	182.28	47.12	16.69	3.27	0.98	0.65	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	64.85	14.31	3.96	0.61	0.61	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	501.89	332.16	346.30	27.62	2.21	0.66	0.66	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	498.07	410.93	215.15	26.89	3.94	2.15	0.72	2.15
Alveolar Epithelial Cells, donor3	11671-122G6	402.53	198.87	75.47	8.39	1.20	2.40	1.20	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	471.89	111.36	11.69	3.06	1.08	1.26	0.54	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	254.37	60.25	3.35	5.02	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	411.31	159.22	27.12	6.16	2.05	1.44	3.08	0.41
Anulus Pulposus Cell, donor1	11248-116E6	386.30	48.06	1.26	0.80	1.49	0.34	0.34	0.80
Anulus Pulposus Cell, donor2	11463-119B5	349.24	48.74	2.20	0.49	2.69	0.73	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	229.14	65.15	45.83	8.09	6.74	4.49	0.00	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	255.27	76.41	62.52	13.89	3.04	1.30	0.87	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	231.15	92.03	55.65	14.98	8.56	2.14	4.28	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	256.18	69.05	42.75	7.17	3.59	0.60	1.49	1.49
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	250.40	55.64	49.32	11.38	1.26	5.06	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	249.51	89.77	47.53	10.56	2.64	2.64	0.66	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	230.67	58.48	43.86	9.10	2.92	1.62	1.30	2.27
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	270.39	67.96	36.89	10.68	1.46	0.49	1.46	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	267.84	92.05	46.92	10.10	2.97	3.56	1.19	5.34
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	244.44	51.98	44.44	5.27	4.52	2.26	1.88	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	232.94	49.35	44.27	10.89	0.73	0.73	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	218.16	94.03	36.36	8.78	3.76	3.76	1.25	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	327.33	81.71	45.80	14.17	1.15	0.33	1.48	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	222.46	53.23	45.04	9.55	1.36	1.36	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	223.77	54.59	43.13	9.35	1.51	0.15	0.90	0.90
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	252.36	56.26	57.33	12.86	2.68	1.07	0.54	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	336.68	74.82	64.05	13.23	2.83	0.94	0.94	1.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	319.14	98.09	68.43	12.03	3.21	2.14	1.87	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	192.16	54.63	54.63	17.56	2.93	3.90	0.00	4.88
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	317.79	70.66	54.90	12.44	1.99	1.00	1.00	1.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	222.13	97.26	42.03	9.61	3.60	2.40	1.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	212.41	74.34	60.18	10.62	0.00	3.54	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	324.36	74.27	60.04	10.29	2.92	2.40	1.54	1.37
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	222.33	96.48	54.53	0.00	4.19	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	246.60	64.08	53.40	10.19	3.40	0.00	0.97	2.43
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	352.51	88.03	64.13	12.14	1.52	0.76	1.52	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	307.69	82.37	60.57	2.42	1.21	1.21	4.85	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	221.74	50.16	50.73	9.12	2.28	1.14	2.28	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	323.44	75.46	58.57	11.54	1.50	0.86	0.64	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	273.32	71.75	68.14	13.16	3.10	2.06	1.29	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	266.98	65.69	61.94	9.85	3.28	1.41	0.94	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	302.90	77.49	52.41	7.72	1.61	1.29	0.32	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	232.59	67.06	52.08	12.13	2.85	0.00	1.43	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	217.02	57.91	54.99	5.26	1.75	2.92	1.17	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	311.61	81.89	56.30	9.63	2.41	0.30	0.60	1.81
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	270.86	71.28	77.22	11.88	9.50	3.56	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	269.03	57.98	51.36	7.63	2.03	1.02	2.54	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	319.38	59.60	53.48	10.95	3.57	1.53	0.51	1.78
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	232.54	76.24	47.65	10.80	3.18	1.27	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	264.96	63.87	44.88	9.49	1.73	1.73	2.59	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	310.12	67.10	55.67	11.64	1.27	0.64	1.27	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	234.02	75.11	48.14	10.73	3.19	0.58	2.32	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	223.90	49.13	58.57	5.67	3.78	0.00	3.78	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	293.79	62.39	48.65	11.53	1.53	0.68	2.54	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	252.48	76.44	64.86	20.85	2.32	4.63	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	196.47	50.70	67.60	2.11	0.00	4.23	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	310.25	80.62	62.82	9.22	1.93	1.93	0.64	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	261.72	103.49	51.14	10.23	2.41	1.20	4.21	3.01
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	207.03	45.93	42.28	4.37	2.19	1.46	2.19	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	319.99	66.67	54.25	10.34	1.61	2.07	1.15	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	293.28	79.06	45.91	10.20	2.55	7.65	7.65	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	200.59	57.20	49.58	9.66	1.78	0.51	0.76	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	355.28	78.86	58.84	11.15	1.03	1.65	1.24	1.45
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	243.88	74.36	52.94	12.55	2.14	1.84	1.22	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	233.75	50.67	45.41	12.91	4.30	1.43	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	295.80	70.96	64.97	12.64	2.88	0.89	0.89	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	212.09	64.08	53.40	0.00	3.05	6.10	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	196.63	43.76	34.34	5.54	1.11	0.00	0.00	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	303.19	64.87	57.46	8.47	3.71	1.06	2.12	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	228.61	77.41	45.79	9.81	3.27	0.73	1.09	0.36
Astrocyte - cerebellum, donor1	11500-119F6	978.11	291.07	40.90	8.11	2.21	0.98	0.86	0.49
Astrocyte - cerebellum, donor2	11580-120F5	857.51	193.07	30.30	4.96	4.28	1.88	1.37	2.23
Astrocyte - cerebellum, donor3	11661-122F5	659.03	318.61	161.09	26.01	3.57	1.89	1.68	1.89
Astrocyte - cerebral cortex, donor1	11235-116D2	457.34	184.75	74.25	21.96	2.44	1.05	0.35	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	488.39	200.11	70.37	17.96	5.18	3.07	1.94	1.62
Astrocyte - cerebral cortex, donor3	11392-118C6	626.92	282.51	156.32	33.56	7.31	2.68	1.94	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	202.76	26.72	8.83	5.28	1.03	0.80	0.11	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	222.50	33.32	12.53	5.39	0.38	1.00	1.13	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	184.24	23.90	6.03	4.67	1.48	0.68	0.34	0.34
Basophils, donor1	12241-129G9	631.60	172.09	5.75	4.71	1.05	0.78	1.57	0.26
Basophils, donor2	12242-129H1	924.72	175.71	16.60	28.14	3.25	1.08	1.08	0.00
Basophils, donor3	12243-129H2	644.73	116.72	4.26	2.65	1.47	0.00	1.03	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	418.92	225.95	56.92	14.01	1.29	0.86	1.29	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	812.42	383.12	38.40	8.23	3.20	3.66	0.46	2.74
Bronchial Epithelial Cell, donor3	11672-122G7	100.43	71.74	21.52	7.17	0.00	7.17	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	438.73	146.87	11.30	3.77	4.39	1.88	3.77	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	628.63	190.48	6.45	3.12	3.54	2.29	2.29	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	509.63	118.37	2.07	1.15	5.99	3.68	2.53	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	225.47	78.46	12.60	5.04	2.34	1.08	0.72	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	26.28	2.06	0.00	0.00	0.21	0.10	0.00	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	127.63	9.78	0.00	0.00	0.00	0.70	0.23	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	130.47	13.43	0.00	0.00	0.96	0.00	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	113.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	674.58	108.77	2.25	3.38	3.38	0.00	1.13	0.56
CD14+ Monocytes, donor2	11305-117B9	660.37	132.15	3.53	5.38	2.97	2.97	1.86	1.67
CD14+ Monocytes, donor3	11381-118B4	607.02	84.30	2.63	2.41	2.41	1.32	1.76	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	116.33	7.93	0.57	0.28	0.28	0.28	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	224.79	21.99	0.00	0.00	0.38	0.00	0.00	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	169.63	11.51	0.00	0.00	0.33	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	505.49	173.89	0.58	1.01	6.22	2.46	2.31	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	468.91	133.37	0.00	0.00	3.92	0.91	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	579.91	180.51	0.47	0.95	5.45	1.42	1.66	1.42
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	529.98	290.77	0.67	0.67	7.53	3.01	1.84	2.18
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	556.16	236.82	0.00	0.28	5.52	2.21	1.93	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	795.36	337.43	0.25	0.74	4.96	1.98	0.99	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	554.31	232.02	0.39	0.39	4.31	3.13	1.37	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	499.96	198.70	0.18	0.18	5.70	1.78	0.71	1.78
CD14+ monocytes - treated with BCG, donor3	11880-125C8	645.27	201.09	0.22	0.00	6.96	1.31	1.74	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	637.06	253.09	2.34	1.87	5.15	2.34	1.87	1.40
CD14+ monocytes - treated with Candida, donor2	11878-125C6	691.19	211.21	1.06	0.00	6.34	0.53	3.17	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	758.80	305.07	0.00	0.00	2.22	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	532.67	281.28	2.53	2.08	8.18	3.72	1.04	1.34
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	596.85	204.34	0.00	0.40	5.19	1.80	1.60	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	612.31	199.25	0.42	0.21	4.79	1.04	2.29	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	761.62	414.79	1.60	3.43	9.61	5.49	2.97	1.60
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	800.08	253.35	0.00	0.23	3.62	0.90	1.13	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	803.52	270.17	0.44	0.87	8.73	0.87	0.87	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	352.91	106.79	0.00	0.27	2.96	2.15	1.88	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	436.85	126.66	0.52	0.17	4.88	0.52	2.27	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	545.80	130.88	0.00	0.00	5.05	0.42	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	838.82	385.43	1.65	1.29	9.55	5.70	2.76	2.39
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	903.91	299.43	0.00	0.00	8.45	2.47	2.11	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1059.52	358.88	0.00	0.00	8.77	2.19	1.75	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	434.71	242.90	1.22	1.22	4.36	2.79	2.44	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	544.51	191.41	0.37	0.00	4.46	2.23	0.74	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	690.62	232.79	0.00	0.43	4.96	1.29	1.29	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	736.26	275.99	6.55	2.87	7.78	4.09	1.64	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	896.13	263.09	0.23	0.23	2.55	1.16	0.23	1.16
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	768.13	219.00	0.00	0.00	5.10	2.55	0.70	1.39
CD14+CD16+ Monocytes, donor1	11789-124B7	388.63	120.53	0.00	0.22	3.49	0.44	1.31	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	404.01	164.01	0.23	0.23	3.00	1.15	0.46	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	309.54	96.39	0.00	0.22	1.52	0.43	1.08	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	510.30	136.57	0.00	0.78	2.49	0.47	1.71	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	457.22	112.30	0.00	0.70	2.45	0.87	1.05	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	585.29	118.62	0.00	0.45	2.68	0.89	0.89	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	337.34	166.63	0.00	0.51	3.57	0.77	1.53	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	374.58	210.78	0.00	0.22	3.07	1.98	1.54	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	369.93	199.18	0.00	0.21	1.47	1.05	0.63	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	189.00	30.48	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	210.85	30.51	0.68	0.68	2.03	0.00	0.68	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	224.72	37.28	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	196.16	24.52	0.00	0.00	0.53	0.53	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	263.21	35.38	0.00	0.00	0.54	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	234.45	33.69	0.70	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	217.27	28.24	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	206.97	26.37	0.00	0.00	0.00	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	352.60	36.99	0.82	0.00	1.64	0.82	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	369.24	43.53	1.45	0.00	1.45	1.45	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	399.82	39.38	0.50	1.01	2.02	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	42.43	15.35	5.25	1.62	0.00	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	29.56	9.59	6.79	0.40	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	123.50	31.13	6.02	0.00	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	339.33	41.01	1.12	0.56	0.56	1.69	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	216.81	25.93	1.88	0.75	0.38	0.00	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	189.63	27.96	2.48	0.23	0.23	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	481.31	90.69	0.71	1.43	2.50	0.36	0.00	0.71
CD4+ T Cells, donor2	11306-117C1	609.30	135.33	2.45	4.90	6.12	4.29	1.22	6.12
CD4+ T Cells, donor3	11382-118B5	756.69	172.02	5.49	5.49	5.79	1.52	1.83	2.74
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	639.11	72.49	0.51	4.34	5.36	1.79	0.51	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	673.12	81.08	2.02	2.25	2.02	0.67	0.90	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	708.59	65.83	2.30	3.45	4.31	2.01	1.15	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	225.19	27.97	0.00	0.47	1.90	0.95	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	243.71	34.41	0.70	0.00	1.40	1.40	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	253.81	46.15	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	542.22	81.07	7.23	7.51	4.77	1.59	1.30	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	622.78	113.88	9.32	11.02	3.39	2.88	3.22	1.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	562.45	76.41	8.87	10.32	4.19	2.58	1.29	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	401.23	90.56	0.90	3.14	3.59	0.90	0.00	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	457.35	88.40	0.00	1.05	3.49	1.40	2.45	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	1024.72	139.47	1.76	1.32	3.08	2.64	2.20	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	428.81	46.38	2.53	5.06	1.26	0.84	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	303.14	27.22	5.19	4.36	1.45	0.83	0.83	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	282.67	26.73	6.01	4.68	1.67	1.00	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	274.93	41.06	0.00	0.54	1.90	0.54	0.27	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	272.80	30.55	0.00	0.00	3.22	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	369.40	30.48	1.79	0.00	3.59	3.59	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	660.50	108.29	15.21	15.02	3.15	0.93	2.04	0.74
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	648.77	78.63	6.93	8.45	2.38	1.73	0.87	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	816.44	101.29	19.33	19.33	4.20	1.89	1.89	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	469.71	87.47	2.02	2.02	2.53	2.02	1.01	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	400.76	82.75	0.43	2.17	4.77	1.30	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	814.54	118.11	1.74	4.36	6.54	1.31	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	588.89	127.68	4.45	5.94	1.48	0.99	1.48	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	527.14	93.24	3.69	3.69	0.92	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	456.43	71.19	2.79	9.77	2.79	2.79	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	821.37	148.99	14.68	9.42	1.38	1.66	0.55	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	1039.97	199.01	10.06	6.63	1.72	1.72	0.49	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	777.70	190.96	7.70	7.70	1.54	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	803.62	163.66	5.73	5.37	1.43	1.07	0.36	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	731.28	108.03	2.77	5.54	0.00	1.38	0.00	5.54
CD8+ T Cells, donor1	11226-116C2	1003.47	159.11	6.88	10.48	5.57	0.33	0.98	1.31
CD8+ T Cells, donor2	11307-117C2	1033.56	170.45	10.14	19.15	9.01	3.38	3.75	3.75
CD8+ T Cells, donor3	11383-118B6	794.33	103.02	5.05	10.35	4.80	2.52	2.02	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	362.44	146.58	170.21	16.29	3.67	1.15	0.46	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	311.77	133.48	163.20	15.10	3.12	1.92	0.48	1.44
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	272.22	130.50	141.72	16.14	5.47	1.64	0.82	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	344.94	155.81	94.27	14.71	5.40	1.50	2.70	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	361.17	135.35	145.91	16.80	3.12	0.72	0.72	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	339.49	118.47	140.07	12.28	2.73	0.91	0.68	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	308.11	107.34	140.15	13.69	2.61	1.09	0.00	1.52
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	288.47	116.07	128.18	14.21	4.47	0.53	2.11	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	291.97	104.59	132.03	14.31	4.22	2.11	0.23	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	240.60	76.37	67.32	9.96	1.81	0.00	0.00	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	222.24	71.75	58.10	10.17	1.74	0.58	1.16	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	261.11	67.14	73.00	10.12	2.40	1.60	0.53	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	329.63	60.85	54.28	7.00	0.44	0.44	0.88	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	318.80	84.71	56.93	10.47	0.91	0.91	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	244.65	56.69	35.80	4.48	2.24	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	399.77	128.58	133.26	15.85	1.08	0.36	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	340.37	110.49	121.13	14.39	2.88	1.44	0.58	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	302.63	131.05	123.74	15.32	1.65	1.18	1.89	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	327.68	93.49	116.94	16.16	3.80	0.63	0.95	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	302.33	108.26	132.87	14.76	3.08	0.62	0.62	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	304.23	99.70	114.77	13.46	2.24	0.32	0.64	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	237.51	58.52	64.25	9.56	1.53	0.00	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	228.97	61.48	59.90	9.46	0.79	0.79	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	198.94	58.24	53.71	12.86	0.76	0.76	0.00	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	236.07	81.90	34.53	5.62	0.80	0.00	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	240.60	63.65	34.97	6.99	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	244.43	66.12	36.06	10.02	4.01	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	833.45	131.60	16.45	1.83	0.00	0.00	0.00	7.31
Cardiac Myocyte, donor2	11605-120I3	337.96	44.47	4.94	1.98	1.98	1.48	1.48	0.00
Cardiac Myocyte, donor3	11686-122I3	408.09	214.25	105.65	16.31	0.53	0.84	0.32	0.63
Chondrocyte - de diff, donor1	11261-116G1	521.73	149.76	64.83	20.11	2.77	2.43	0.69	0.35
Chondrocyte - de diff, donor2	11338-117F6	756.60	215.36	103.06	25.94	2.13	2.84	1.07	2.84
Chondrocyte - de diff, donor3	11410-118E6	405.39	62.24	26.06	10.24	2.62	1.37	0.91	1.71
Chondrocyte - re diff, donor2	11339-117F7	599.82	66.25	6.27	4.48	2.69	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	323.93	46.51	21.03	6.87	2.83	2.02	0.40	2.02
Ciliary Epithelial Cells, donor1	11242-116D9	619.12	220.79	70.58	18.13	2.75	0.80	1.95	0.92
Ciliary Epithelial Cells, donor2	11323-117D9	464.09	259.73	136.38	23.51	6.20	4.06	1.28	2.78
Ciliary Epithelial Cells, donor3	11399-118D4	548.95	215.76	108.14	17.08	4.42	2.74	2.12	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	228.15	151.31	324.53	58.32	1.56	0.92	0.28	1.01
Corneal Epithelial Cells, donor1	11526-119I5	785.19	252.07	23.93	6.15	2.20	0.88	1.76	1.32
Corneal Epithelial Cells, donor2	11606-120I4	320.80	133.10	46.64	17.06	5.69	5.69	0.00	2.28
Corneal Epithelial Cells, donor3	11687-122I4	454.51	156.19	28.63	7.92	1.79	1.53	0.51	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	675.57	171.20	47.22	15.85	2.48	0.83	1.98	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	664.25	160.23	44.16	14.19	2.84	0.63	1.89	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	586.62	100.07	6.90	6.90	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	675.15	171.16	43.41	12.96	4.64	3.78	1.73	2.48
Dendritic Cells - plasmacytoid, donor1	11228-116C4	134.61	12.64	0.00	0.00	0.00	0.68	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	112.95	5.88	0.00	0.65	1.31	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	107.92	3.87	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	650.40	141.59	31.02	11.84	2.17	0.83	1.00	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	460.62	88.60	17.60	7.63	2.35	0.59	1.76	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	781.09	180.71	25.73	9.62	0.85	0.57	0.00	1.70
Endothelial Cells - Aortic, donor3	11412-118E8	726.21	170.25	46.79	11.01	3.54	0.39	2.36	3.15
Endothelial Cells - Artery, donor1	11264-116G4	504.96	113.73	44.50	9.89	2.04	0.29	0.29	1.16
Endothelial Cells - Artery, donor2	11341-117F9	555.96	124.93	27.53	11.76	2.82	4.00	1.18	1.41
Endothelial Cells - Artery, donor3	11413-118E9	609.55	144.98	63.64	16.48	4.21	4.56	0.88	1.23
Endothelial Cells - Lymphatic, donor1	11236-116D3	409.61	118.36	4.88	2.66	0.89	0.22	0.22	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	384.29	130.23	10.95	0.91	1.83	0.30	0.61	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	354.35	111.35	8.74	3.95	0.56	0.28	0.56	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	645.37	111.13	16.64	2.08	1.19	1.19	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	347.28	69.25	14.06	3.12	2.08	0.00	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	449.89	102.65	14.46	4.25	3.54	2.41	0.71	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	534.56	86.03	11.60	1.60	2.00	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	458.08	110.59	33.02	8.39	2.62	3.14	2.10	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	409.76	77.16	6.59	1.86	1.62	0.62	0.25	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	264.84	45.41	5.43	1.74	1.09	0.65	0.22	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	270.27	46.29	4.64	1.59	0.61	0.24	0.37	0.61
Endothelial Cells - Vein, donor1	11267-116G7	608.57	122.85	12.51	5.69	1.14	0.00	1.14	1.14
Endothelial Cells - Vein, donor2	11344-117G3	886.40	166.24	11.18	5.59	1.40	1.40	2.10	1.40
Endothelial Cells - Vein, donor3	11416-118F3	539.32	86.67	5.34	2.83	2.67	1.57	0.79	1.10
Eosinophils, donor1	12244-129H3	609.88	76.23	30.49	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1165.09	404.31	1.65	6.60	3.30	0.00	9.90	0.00
Eosinophils, donor3	12246-129H5	363.82	135.54	7.13	3.57	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	523.84	273.40	31.27	4.64	1.71	0.73	0.98	0.98
Esophageal Epithelial Cells, donor2	11587-120G3	187.21	183.05	64.49	10.40	0.00	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	211.49	65.08	0.00	0.00	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	416.67	243.44	224.14	42.28	6.16	1.23	4.11	2.87
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	161.93	37.66	20.80	3.18	5.80	0.66	2.30	1.20
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	285.36	57.09	20.04	5.20	3.58	0.76	0.43	1.95
Fibroblast - Aortic Adventitial, donor1	11245-116E3	537.39	226.91	80.65	20.01	4.37	2.18	2.18	1.94
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	1006.07	377.34	104.81	17.60	1.91	1.91	7.23	2.18
Fibroblast - Aortic Adventitial, donor2	11326-117E3	500.77	160.63	109.58	26.26	5.17	4.54	2.00	3.06
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	882.17	389.18	54.54	7.38	6.06	1.58	2.90	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	473.38	89.03	26.24	8.30	3.32	2.66	0.66	1.00
Fibroblast - Cardiac, donor1	11268-116G8	511.69	231.80	220.92	29.03	4.08	1.81	2.27	0.91
Fibroblast - Cardiac, donor2	11345-117G4	853.45	459.32	420.66	80.34	9.85	5.31	3.03	2.27
Fibroblast - Cardiac, donor3	11417-118F4	511.47	184.21	145.10	29.34	3.79	3.00	2.05	1.73
Fibroblast - Cardiac, donor4	11452-119A3	367.37	79.72	9.09	2.42	2.12	0.00	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	367.01	104.32	25.63	6.09	2.16	2.28	0.63	0.38
Fibroblast - Cardiac, donor6	11460-119B2	349.42	95.05	17.28	4.09	1.82	1.52	1.06	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	580.71	127.02	20.37	4.56	1.88	0.40	1.47	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	369.30	43.57	3.45	1.29	2.16	0.86	0.86	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	322.25	153.80	41.01	2.93	4.39	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	848.98	104.25	8.07	2.31	0.69	0.69	0.69	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	398.57	84.29	6.78	3.90	1.53	1.02	0.17	0.51
Fibroblast - Dermal, donor1	11269-116G9	287.61	28.41	1.17	0.00	1.41	0.94	0.70	1.17
Fibroblast - Dermal, donor2	11346-117G5	416.96	58.49	3.77	2.83	1.89	0.94	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	336.67	45.21	1.81	1.81	2.06	2.06	0.85	1.09
Fibroblast - Dermal, donor4	11450-119A1	314.83	54.26	2.26	0.34	2.03	1.24	0.23	0.57
Fibroblast - Dermal, donor5	11454-119A5	327.62	73.62	6.45	1.92	2.27	1.57	0.35	0.52
Fibroblast - Dermal, donor6	11458-119A9	348.89	67.41	3.57	2.44	1.46	0.81	0.32	0.16
Fibroblast - Gingival, donor1	11237-116D4	371.27	62.68	0.62	1.04	1.04	0.21	1.04	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	865.91	195.19	67.33	22.53	5.50	2.36	2.36	2.36
Fibroblast - Gingival, donor2	11318-117D4	375.45	73.80	4.48	1.84	2.77	2.11	1.58	0.79
Fibroblast - Gingival, donor3	11394-118C8	408.12	42.16	2.13	1.35	1.64	1.06	1.16	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	559.96	174.53	161.03	50.91	1.04	0.00	1.04	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	492.49	223.43	263.07	71.54	8.81	4.41	1.94	1.23
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	546.57	95.56	21.51	8.42	2.65	0.31	0.94	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	501.69	97.23	40.57	11.76	2.70	1.08	1.76	1.35
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	393.11	158.44	222.67	50.46	0.35	0.35	1.06	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	505.42	169.20	84.38	23.25	1.46	0.88	2.05	1.02
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	548.00	144.81	37.36	11.73	2.45	1.09	1.64	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	454.35	180.88	109.14	27.42	3.07	1.10	1.97	1.54
Fibroblast - Gingival, donor9 (control)	11927-125I1	605.59	143.36	72.78	24.80	4.55	1.61	1.47	1.61
Fibroblast - Lung, donor1	11270-116H1	777.55	82.92	12.23	5.44	1.36	1.36	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	513.30	50.73	4.48	1.49	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	465.33	36.72	4.22	1.90	3.59	1.48	0.00	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	1579.41	278.23	34.15	4.17	0.83	2.50	0.00	2.50
Fibroblast - Lymphatic, donor2	11586-120G2	709.10	146.86	22.38	6.99	1.40	2.80	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	749.51	176.60	30.23	10.92	3.36	2.24	1.40	1.40
Fibroblast - Mammary, donor1	11540-120B1	918.30	138.44	19.49	4.06	1.22	0.41	1.22	1.62
Fibroblast - Mammary, donor2	11620-122A9	718.96	195.72	19.97	3.99	3.99	3.99	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	690.93	244.21	65.52	35.74	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	368.74	72.35	3.30	3.49	1.94	0.58	0.39	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	390.73	82.06	5.92	1.97	2.28	1.97	0.46	1.21
Fibroblast - Periodontal Ligament, donor3	11395-118C9	400.23	65.79	4.28	0.92	0.92	0.31	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	704.86	195.77	144.64	33.96	2.29	2.67	2.29	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	668.77	293.21	206.81	61.29	10.53	3.78	3.24	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	507.97	186.14	252.36	69.93	4.41	1.16	1.39	1.16
Fibroblast - Pulmonary Artery, donor1	11250-116E8	269.81	116.61	67.98	14.04	1.55	0.77	0.99	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	1052.53	223.71	46.33	13.61	1.22	1.02	1.63	2.84
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	574.65	108.92	12.70	6.68	2.67	2.00	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	357.41	66.03	9.49	5.14	0.79	0.40	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	2399.83	1285.35	280.01	48.82	8.53	7.94	6.15	3.57
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	594.84	245.29	220.07	47.78	3.73	2.49	1.42	1.42
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	596.77	285.97	232.76	45.13	5.32	1.77	1.18	1.38
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	1809.94	646.84	152.23	34.00	5.42	5.11	5.42	2.41
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	820.22	196.58	78.05	17.27	2.59	2.48	0.97	1.30
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	2411.80	757.96	191.83	37.46	8.60	6.58	3.29	2.28
Fibroblast - skin normal, donor1	11553-120C5	1017.45	263.18	118.14	32.65	4.76	2.79	0.82	1.80
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	1507.21	666.69	157.40	30.68	3.61	2.61	4.61	2.01
Fibroblast - skin normal, donor2	11561-120D4	1061.89	376.93	138.54	25.62	5.53	3.72	2.61	1.51
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	2734.64	1217.41	349.99	58.63	10.88	6.35	4.23	3.32
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	663.43	282.59	190.88	47.06	2.82	2.07	1.49	0.75
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	555.93	118.64	38.81	11.80	3.08	1.88	0.85	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	1680.59	884.47	358.98	48.61	8.21	6.90	4.93	2.63
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	790.07	299.86	190.14	32.92	4.26	1.81	1.60	1.28
Fibroblast - skin walker warburg, donor1	11554-120C6	868.88	290.13	191.79	43.01	4.22	1.35	1.69	1.35
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	423.10	63.67	24.46	10.19	3.92	1.73	0.63	2.51
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	354.56	44.32	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	89.77	17.43	14.82	20.05	0.87	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	318.80	104.01	3.64	1.56	1.21	0.52	1.73	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	419.77	134.02	3.12	1.82	2.08	0.78	2.60	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	369.22	102.72	6.64	2.04	0.51	0.77	2.30	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	224.31	173.78	6.89	1.53	2.30	3.06	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	188.23	208.65	2.55	0.00	5.10	1.91	1.28	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	228.50	183.14	1.43	0.29	1.14	2.28	1.14	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	298.37	57.08	3.31	0.55	2.21	1.65	0.55	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	278.10	83.57	5.71	0.91	2.05	0.68	0.91	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	230.62	149.59	5.15	0.99	1.19	1.39	0.99	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	272.27	57.10	3.44	0.00	1.59	1.06	0.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	321.91	60.34	4.57	1.30	2.28	1.30	0.98	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	200.33	274.62	4.86	1.77	2.65	1.33	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	268.23	141.18	7.63	1.13	1.27	1.27	0.28	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	302.56	109.84	10.22	2.09	1.72	1.11	0.86	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	225.65	194.22	8.60	2.69	1.61	0.81	0.27	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	333.65	120.67	15.49	1.36	1.86	1.73	0.74	1.49
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	334.02	197.95	12.32	1.94	2.21	1.38	0.97	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	234.81	230.55	9.15	2.44	2.03	1.22	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	260.35	101.77	16.20	1.83	0.23	1.83	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	289.24	93.05	11.09	2.62	1.49	1.74	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	261.64	161.09	9.40	1.97	1.09	0.22	0.87	1.31
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	237.27	67.96	8.86	2.36	0.89	0.59	0.59	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	310.76	69.78	10.17	2.07	2.07	1.91	1.11	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	275.48	90.93	7.15	2.23	1.56	0.89	0.89	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	269.58	79.44	5.65	1.61	2.62	0.81	1.01	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	325.88	59.54	6.79	1.36	0.34	0.51	0.17	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	348.75	147.46	10.55	2.57	1.33	0.89	0.53	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	396.14	87.30	7.08	2.71	1.14	0.62	0.62	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	459.73	76.85	7.17	1.02	1.20	0.17	0.51	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	309.39	47.80	4.54	1.88	1.00	1.11	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	301.92	89.27	6.16	1.75	0.67	0.50	0.83	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	344.66	79.22	5.72	1.63	0.82	0.41	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	298.32	69.94	9.90	2.48	1.24	1.65	0.83	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	315.67	51.19	7.49	1.61	0.23	1.04	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	289.84	59.37	3.84	1.33	1.67	0.33	0.67	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	245.34	44.53	3.53	1.98	1.10	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	310.31	34.19	5.17	0.98	1.23	0.98	0.61	0.86
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	260.81	59.16	4.38	0.97	1.13	0.81	0.49	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	245.03	33.03	1.92	0.64	0.32	2.25	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	311.36	44.35	7.01	2.37	0.95	0.66	0.38	0.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	270.80	49.98	2.85	1.58	1.11	0.16	0.79	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	299.83	49.87	4.87	1.52	1.82	0.91	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	345.39	58.12	8.26	0.63	1.25	1.36	0.84	0.94
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	269.61	31.62	2.42	0.88	0.88	0.22	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	260.91	57.79	5.61	0.56	1.40	0.00	0.56	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	407.85	51.02	8.52	1.85	1.85	1.39	0.93	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	279.97	55.35	3.74	3.21	1.07	1.34	1.07	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	311.67	49.73	3.21	1.07	0.61	1.07	0.92	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	347.68	52.20	12.05	2.46	1.04	1.17	0.91	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	257.79	39.31	5.69	2.17	1.90	0.27	0.54	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	357.64	120.57	16.59	2.77	2.58	1.29	1.29	1.29
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	391.47	159.66	27.85	7.02	1.97	1.97	1.54	1.75
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	220.17	42.65	4.96	2.98	1.98	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	514.06	184.28	33.77	11.21	1.71	2.64	1.85	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	525.98	160.80	28.25	8.07	2.62	3.63	1.61	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	208.16	57.69	7.88	3.30	0.51	0.00	0.00	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	366.07	397.32	7.56	0.80	1.19	1.39	1.19	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	305.84	178.27	6.01	0.31	2.16	1.39	1.39	0.92
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	415.92	250.61	8.80	1.64	2.25	1.84	0.82	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	188.07	155.84	5.63	0.63	1.88	0.00	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	140.15	125.17	4.80	0.00	1.41	0.57	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	203.39	176.64	3.69	0.00	0.92	0.46	0.46	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	215.31	178.19	7.42	2.47	2.47	0.00	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	216.23	163.23	3.48	0.00	1.55	2.32	0.39	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	173.28	158.84	3.21	0.00	3.21	0.00	0.00	4.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	241.70	126.93	0.00	1.74	10.43	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	180.32	94.06	1.95	0.00	1.30	1.30	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	183.66	107.07	2.47	0.41	1.24	2.88	1.65	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	186.61	89.97	3.33	0.00	6.66	6.66	3.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	184.29	70.47	1.68	0.28	1.68	0.84	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	182.05	90.21	2.94	1.31	0.65	0.98	0.65	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	223.97	78.85	2.52	0.00	0.00	1.68	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	210.56	70.93	1.27	0.32	1.59	1.59	0.32	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	204.82	81.52	0.34	0.34	2.04	0.68	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	183.76	50.12	2.09	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	212.47	66.43	2.86	0.00	1.15	1.15	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	201.86	64.52	1.18	0.30	0.59	0.59	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	193.13	76.24	5.08	0.00	5.08	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	203.79	62.13	3.73	0.00	1.66	2.49	0.41	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	203.89	56.38	1.38	0.00	0.92	0.92	0.46	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	210.74	68.49	5.27	0.00	10.54	0.00	0.00	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	169.53	40.75	1.54	0.00	0.77	1.15	0.38	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	157.77	35.20	2.93	0.00	0.98	0.00	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	124.40	44.14	6.69	0.00	2.01	0.67	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	167.21	30.05	1.93	0.39	0.39	1.93	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	264.29	80.79	6.85	0.68	2.40	0.34	1.03	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	208.72	37.27	9.94	2.48	7.45	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	146.27	32.56	2.36	0.00	0.94	0.47	1.89	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	167.17	39.23	3.62	0.00	0.60	1.81	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	182.61	42.73	0.51	1.53	0.51	1.02	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	195.03	37.49	2.39	0.80	1.20	1.99	0.80	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	167.25	30.59	1.48	0.49	0.99	1.48	0.49	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	166.44	51.94	5.90	1.18	2.36	0.00	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	164.53	28.59	2.92	0.00	2.92	0.00	1.17	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	168.09	28.09	2.63	0.88	0.88	1.32	0.44	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	155.13	22.04	2.54	0.00	1.70	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	165.94	29.25	2.39	1.19	1.79	0.00	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	170.81	37.85	6.31	0.49	1.46	0.49	0.00	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	818.31	131.25	141.52	36.52	7.99	5.71	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	620.81	182.13	143.87	28.28	3.74	8.73	1.25	2.49
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	883.82	145.05	44.98	22.49	12.37	2.25	6.75	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	382.50	65.97	10.47	2.22	3.49	0.95	1.90	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	332.52	50.13	1.67	0.84	0.84	1.67	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	305.65	74.85	51.87	13.23	2.32	1.28	0.81	1.39
Hep-2 cells mock treated, biol_rep2	11899-125E9	384.19	79.34	58.24	16.04	3.21	1.86	0.51	2.03
Hep-2 cells mock treated, biol_rep3	11900-125F1	352.86	65.75	52.10	10.24	1.82	1.14	0.68	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	297.21	80.78	58.48	15.63	2.73	0.98	1.09	1.20
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	394.58	81.67	69.85	18.70	2.79	1.07	1.72	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	333.04	64.58	50.81	12.27	3.23	2.80	1.08	2.15
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	232.14	48.07	30.76	10.21	2.49	0.75	0.75	0.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	242.74	43.75	26.59	10.46	1.54	1.03	1.03	1.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	270.71	43.25	33.64	8.33	1.28	0.96	0.96	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	439.30	101.85	7.28	1.12	1.12	0.56	1.68	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	680.35	225.49	100.84	15.15	3.03	3.90	0.87	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	237.94	55.52	7.93	2.64	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	974.92	343.55	144.62	19.75	3.53	1.76	1.06	2.12
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	749.76	404.67	313.85	45.77	2.91	0.73	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	361.92	79.03	23.08	3.15	2.27	2.45	0.70	0.35
Hepatocyte, donor1	11523-119I2	9.68	1.21	0.00	1.21	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	12.93	6.46	1.08	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	73.62	7.36	2.45	0.00	0.00	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	86.15	2.61	0.00	0.00	1.31	0.65	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	122.52	29.71	10.66	1.57	0.17	0.17	0.17	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	344.80	112.24	14.82	3.70	0.96	0.55	0.69	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	369.33	60.49	3.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	427.22	13.35	0.00	0.00	0.00	6.68	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	270.83	27.08	0.00	0.00	0.00	0.00	0.00	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	422.23	22.15	0.00	0.00	5.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	478.01	40.04	0.00	2.50	5.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	189.89	47.47	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	425.44	38.44	0.00	0.00	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	452.51	18.28	4.57	0.00	4.57	0.00	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	422.33	30.86	0.00	1.62	6.50	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	326.79	11.67	0.00	0.00	0.00	0.00	1.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	435.67	21.78	7.26	0.00	3.63	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	415.57	31.76	0.00	1.32	5.29	1.32	0.00	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	299.33	17.74	0.00	1.11	1.11	1.11	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	487.16	31.43	5.24	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	270.21	15.12	1.26	0.63	1.89	1.26	0.00	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	292.31	20.11	3.09	4.64	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	234.16	43.90	0.00	0.00	0.00	0.00	0.00	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	370.18	27.13	1.29	1.29	0.65	2.58	0.65	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	491.03	28.98	3.22	0.00	1.61	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	382.34	35.84	11.95	0.00	0.00	0.00	23.90	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	430.26	18.74	0.81	1.63	1.63	1.63	0.81	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	462.21	41.14	0.84	0.84	2.94	0.84	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	215.59	28.74	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	332.73	18.48	2.41	3.21	3.21	2.41	3.21	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	300.99	23.08	2.77	0.92	1.85	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	241.29	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	254.43	14.16	0.47	0.94	1.89	1.42	0.94	1.89
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	244.88	19.95	3.63	0.00	2.72	1.81	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	309.59	44.23	0.00	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	359.42	22.60	1.08	2.15	1.08	2.15	0.00	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	320.16	30.49	1.27	2.54	1.27	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	427.19	0.00	0.00	0.00	16.43	0.00	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	415.77	28.70	0.64	0.00	0.64	3.19	0.64	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	324.43	20.05	3.65	0.00	3.65	1.82	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	237.07	31.61	0.00	0.00	0.00	0.00	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	409.16	24.99	1.43	1.43	4.28	2.86	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	315.24	43.14	3.32	3.32	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	375.27	0.00	0.00	0.00	0.00	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	276.56	12.35	0.62	0.00	1.23	1.85	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	446.03	40.39	0.00	0.00	5.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	424.32	28.29	0.00	3.14	3.14	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	394.98	25.03	1.39	0.00	2.09	1.39	0.70	3.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	502.37	19.92	2.21	2.21	2.21	2.21	6.64	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	369.59	12.97	3.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	463.00	24.41	3.49	0.87	4.36	1.74	1.74	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	463.46	24.75	0.00	0.00	6.75	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	473.90	24.39	0.00	0.00	6.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	482.18	14.93	1.07	0.00	5.33	0.00	0.00	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	339.43	36.02	6.93	0.00	1.39	1.39	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	416.04	34.20	0.00	0.00	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	370.01	21.17	0.00	0.92	0.00	1.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	366.06	15.13	3.03	0.00	3.03	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	459.44	18.63	6.21	0.00	0.00	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	345.76	11.63	1.06	0.00	1.06	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	408.40	179.27	19.91	4.81	1.55	1.96	1.55	0.90
Keratinocyte - epidermal, donor2	11349-117G8	686.95	142.31	14.06	4.69	1.76	4.10	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	382.41	124.57	18.36	7.00	1.99	1.23	0.85	1.04
Keratinocyte - oral, donor1	11251-116E9	410.93	158.36	9.19	4.65	1.82	0.34	0.57	0.57
Keratocytes, donor1	11527-119I6	1011.90	77.02	14.78	5.85	2.06	0.34	1.38	2.06
Keratocytes, donor2	11607-120I5	489.81	79.68	1.17	0.00	1.17	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	549.91	27.07	15.21	8.30	2.37	0.40	0.40	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	696.74	46.16	21.98	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	346.28	126.21	57.17	8.63	4.31	2.16	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	402.05	86.73	14.07	3.58	0.69	0.23	0.12	0.46
Lens Epithelial Cells, donor3	11690-122I7	579.22	360.25	253.18	40.57	1.41	0.61	3.73	1.31
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	359.64	71.86	8.66	2.96	2.37	0.59	0.47	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	195.91	44.93	5.58	1.67	0.84	1.12	0.84	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	199.76	39.98	4.41	1.26	1.26	0.79	0.31	1.10
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	213.47	29.04	6.99	3.23	3.23	0.54	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	254.02	68.08	6.30	2.52	1.26	1.26	0.63	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	195.47	41.94	5.18	1.51	0.86	0.43	0.43	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	194.12	40.63	5.34	4.51	2.05	1.23	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	236.89	48.54	5.81	2.02	1.52	1.26	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	234.49	43.07	7.18	1.97	0.56	1.27	0.56	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	223.48	44.70	9.89	1.58	1.98	0.79	0.40	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	188.65	45.76	7.56	1.55	1.74	0.97	0.39	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	220.88	47.95	8.70	1.67	1.11	0.74	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	229.26	37.63	8.01	2.44	1.39	0.35	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	201.08	50.33	5.49	1.67	1.43	0.48	0.24	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	199.70	45.60	6.18	2.47	1.51	0.55	0.55	0.82
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	210.64	40.65	5.54	1.85	0.92	0.62	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	211.36	45.20	3.74	1.25	2.49	0.94	0.00	1.56
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	246.49	54.90	6.77	1.65	1.28	0.55	0.37	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	240.58	50.35	8.56	1.65	0.33	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	219.07	47.15	5.27	1.46	2.05	1.46	0.59	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	233.25	46.30	5.73	1.49	0.75	1.24	1.00	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	240.06	44.13	3.88	2.42	0.00	0.97	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	203.05	41.20	6.73	2.15	1.89	0.54	0.81	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	198.61	42.23	7.27	1.36	1.67	1.82	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	203.22	42.51	6.74	0.52	0.52	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	215.88	46.07	6.28	2.93	0.63	0.63	0.42	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	215.63	39.25	4.51	0.45	0.75	0.45	0.45	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	238.69	45.40	7.57	3.44	1.38	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	213.55	41.77	6.40	2.07	1.32	0.19	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	216.62	40.72	6.89	1.59	1.38	0.32	0.21	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	193.35	39.25	8.24	0.97	0.97	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	206.74	43.66	7.61	3.31	0.33	0.33	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	237.50	49.43	7.81	0.87	2.73	1.24	0.62	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	233.97	47.39	5.92	0.74	1.48	0.74	0.37	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	178.39	39.78	5.44	1.24	1.24	0.49	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	217.24	45.92	5.91	0.96	1.37	0.82	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	226.11	45.99	11.58	1.61	1.29	0.64	0.96	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	205.12	42.91	8.52	1.22	0.61	0.91	0.30	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	211.21	46.19	4.76	1.82	0.42	0.98	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	209.07	46.93	9.24	1.42	1.42	0.71	0.36	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	223.48	52.36	9.70	1.45	2.42	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	243.37	49.48	6.69	1.87	1.40	1.40	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	200.90	35.81	6.80	1.43	0.72	1.07	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	236.84	44.75	12.74	2.94	0.98	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	199.40	46.38	7.30	2.83	1.18	1.88	0.24	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	348.48	64.23	11.51	3.22	0.62	0.99	0.62	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	228.72	40.98	7.94	1.79	0.77	1.02	0.77	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	232.72	34.31	5.37	1.79	0.60	1.49	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	330.84	174.48	18.13	6.80	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	370.52	176.44	17.64	3.84	3.84	3.07	1.53	3.07
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	379.28	138.80	14.84	2.23	2.97	0.00	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	440.48	287.73	19.46	5.92	11.42	6.77	2.96	3.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	370.65	187.08	12.66	4.92	3.52	4.22	4.22	4.22
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	368.92	156.91	13.08	3.74	1.87	3.74	0.00	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	366.36	191.16	14.43	3.09	4.12	7.21	2.58	3.09
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	374.68	174.85	15.46	1.19	4.76	4.76	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	393.12	227.55	16.51	6.33	2.26	2.26	0.45	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	253.89	157.05	17.16	5.82	4.07	0.87	0.87	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	317.82	124.25	14.86	3.15	3.15	4.05	0.90	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	560.37	343.05	28.32	12.46	2.85	2.03	1.90	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	368.71	226.98	22.60	3.59	9.24	2.05	1.03	3.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	292.16	144.32	12.70	2.12	3.18	1.76	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	289.18	117.27	11.33	2.00	2.00	0.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	382.55	227.19	18.34	3.06	10.70	5.09	0.51	2.55
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	301.49	140.87	15.47	4.27	2.67	2.40	1.33	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	330.46	161.74	18.71	6.05	3.97	4.16	1.89	1.51
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	355.25	221.50	22.09	6.14	4.91	3.07	1.84	4.91
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	459.90	199.78	20.39	6.52	6.52	11.42	1.63	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	322.78	149.52	16.45	5.00	3.75	2.92	1.46	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	295.11	172.08	14.85	5.61	5.89	3.36	2.24	1.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	424.50	197.83	20.61	2.06	4.12	5.15	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	321.08	171.28	24.68	5.52	7.55	5.52	2.03	2.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	266.05	160.53	15.25	4.48	3.89	2.09	1.49	1.79
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	291.57	125.04	13.28	3.87	4.43	0.55	1.66	2.21
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	484.63	276.43	24.04	7.07	5.30	7.42	3.53	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	338.17	211.31	19.55	5.90	6.64	6.27	2.21	2.58
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	355.74	207.23	17.27	5.76	1.15	5.76	1.15	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	445.54	219.89	27.63	7.29	4.99	4.22	0.38	3.45
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	391.76	251.93	23.21	5.66	10.19	3.96	2.83	3.40
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	384.80	182.14	12.31	2.46	2.46	3.28	2.46	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	436.52	234.08	26.21	8.13	5.87	6.78	4.52	4.52
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	399.29	265.00	18.67	8.62	7.18	3.59	1.44	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	403.33	167.31	16.43	5.23	2.24	2.24	0.75	2.99
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	498.68	279.81	30.47	8.55	7.06	8.55	4.46	4.83
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	354.94	223.99	24.12	3.88	7.32	2.15	1.72	2.15
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	411.88	217.50	27.40	8.56	3.43	2.57	0.86	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	431.46	228.23	22.99	7.00	5.33	5.33	3.00	4.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	390.34	235.89	19.91	7.24	7.24	3.62	1.81	3.02
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	349.81	194.10	17.06	8.53	4.98	1.42	0.00	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	407.99	194.20	26.81	9.28	5.16	3.09	1.03	3.44
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	436.38	286.09	27.91	6.44	6.44	4.83	2.68	3.22
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	421.52	213.46	22.89	6.06	5.39	4.04	2.02	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	464.12	264.47	31.48	7.04	9.63	8.52	4.07	3.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	358.18	220.96	19.77	11.63	5.81	1.16	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	415.69	166.07	23.27	4.23	7.40	2.12	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	455.77	274.50	34.41	7.20	6.40	4.00	1.60	2.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	454.30	292.93	32.71	6.54	7.27	4.36	0.73	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	515.10	223.82	16.10	7.67	6.90	3.07	1.53	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	482.92	247.63	22.20	8.88	7.40	3.95	2.47	2.96
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	462.00	312.39	34.81	3.76	6.59	3.76	2.82	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	536.01	264.48	28.66	7.04	7.04	4.02	1.01	2.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	481.27	273.53	41.46	7.66	9.91	5.41	1.80	4.51
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	471.58	347.66	48.19	3.44	15.49	6.88	1.72	6.88
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	549.55	255.63	43.20	6.23	8.46	3.56	1.34	3.12
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	513.42	286.23	40.67	7.04	8.21	5.87	1.96	4.30
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	403.10	283.03	40.24	7.26	5.28	5.28	1.98	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	497.13	255.83	48.78	8.82	4.15	3.63	1.56	3.11
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	491.39	299.30	47.69	7.00	10.94	5.25	0.88	5.25
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	416.53	325.96	73.80	5.03	6.71	3.91	1.12	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	474.76	286.63	68.45	6.18	7.95	4.42	1.32	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	455.92	263.83	55.93	9.26	8.49	4.24	1.93	3.09
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	396.48	319.51	64.81	10.63	7.09	3.54	1.01	3.04
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	469.57	240.79	68.73	7.69	7.69	3.36	0.48	5.29
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	398.34	271.92	64.80	8.35	4.37	5.57	1.99	6.76
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	379.16	344.52	82.03	10.33	10.33	6.08	1.82	6.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	379.74	268.38	60.18	3.46	6.92	3.46	1.38	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	450.67	308.55	83.22	10.64	4.94	7.60	1.52	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	443.09	378.02	76.43	8.26	12.91	6.20	2.58	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	445.03	364.00	78.00	6.65	7.26	4.23	3.63	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	455.39	298.20	70.04	9.19	7.92	4.12	2.54	3.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	483.51	436.60	109.28	7.46	11.73	3.20	3.20	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	450.54	404.57	71.26	6.90	6.90	1.72	1.72	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	529.66	372.31	106.45	11.31	13.88	10.28	3.09	3.09
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	464.73	424.41	91.96	9.90	6.37	4.95	1.41	5.66
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	514.14	389.86	69.80	5.11	11.35	6.24	1.13	4.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	481.34	319.51	67.40	7.07	8.32	5.82	2.08	3.33
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	486.27	465.91	100.23	14.09	12.53	4.70	3.92	3.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	427.99	357.00	75.16	8.35	2.51	4.18	0.84	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	524.11	348.01	75.27	6.04	8.36	5.58	2.79	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	428.19	383.36	66.24	6.69	8.03	1.34	0.67	4.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	518.07	416.49	83.40	9.09	6.95	3.21	3.21	3.74
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	509.97	370.15	105.47	8.89	10.51	7.27	6.06	6.87
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	429.51	373.53	71.59	8.26	7.34	0.92	3.67	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	467.67	394.76	72.02	12.45	8.00	7.11	0.00	5.33
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	544.80	405.75	105.43	14.25	7.41	2.28	2.28	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	490.05	446.34	88.19	8.44	7.67	4.60	3.83	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	497.38	479.87	95.21	4.92	8.21	3.28	3.83	4.38
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	609.82	410.70	113.59	14.70	8.02	4.90	3.56	4.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	683.16	575.28	131.02	20.54	6.76	5.46	1.04	2.86
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	562.98	557.67	108.09	12.60	7.29	3.98	2.65	3.98
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	488.47	552.91	178.76	10.39	10.39	2.08	0.00	10.39
Macrophage - monocyte derived, donor1	11232-116C8	307.91	76.12	3.87	0.68	1.82	0.23	1.37	0.00
Macrophage - monocyte derived, donor2	11313-117C8	583.74	272.88	45.14	15.05	2.75	1.28	0.92	0.92
Macrophage - monocyte derived, donor3	11389-118C3	532.84	208.42	22.81	6.42	3.54	1.57	1.05	1.05
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	177.89	46.73	6.90	1.59	1.06	0.53	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	558.70	157.03	26.78	8.40	1.90	0.48	1.90	0.79
Mallassez-derived cells, donor3	11930-125I4	400.70	147.74	16.12	3.06	1.39	0.97	1.39	0.14
Mammary Epithelial Cell, donor1	11273-116H4	451.78	103.63	7.97	3.39	0.90	0.40	1.59	0.40
Mammary Epithelial Cell, donor2	11350-117G9	570.12	123.93	10.71	3.19	2.32	0.58	0.87	0.00
Mammary Epithelial Cell, donor3	11422-118F9	699.14	154.89	35.67	14.72	1.75	2.74	1.25	1.25
Mast cell - stimulated, donor1	11487-119E2	300.33	15.59	4.07	0.00	0.00	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	189.46	4.97	0.54	0.32	0.65	0.54	0.32	0.11
Mast cell, donor2	11565-120D8	230.61	18.72	1.78	2.08	1.49	0.00	0.30	0.00
Mast cell, donor3	11566-120D9	88.02	2.93	0.23	0.00	1.35	0.45	0.23	0.00
Mast cell, donor4	11567-120E1	180.83	20.74	1.42	0.53	1.42	0.35	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	440.13	20.52	0.89	0.78	1.11	0.33	0.44	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	437.76	64.21	15.76	1.75	2.33	0.00	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	149.71	3.10	0.34	0.11	0.69	0.23	0.23	0.34
Mast cell, expanded, donor8	11941-126A6	267.62	12.89	2.68	1.17	1.34	0.17	0.50	0.33
Melanocyte - dark, donor1	11502-119F8	250.04	35.92	0.99	0.50	0.60	0.00	0.40	0.40
Melanocyte - dark, donor2	11582-120F7	317.70	38.76	3.46	1.04	1.73	0.69	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	475.43	76.57	3.55	3.19	0.80	0.65	0.29	0.29
Melanocyte - light, donor1	11274-116H5	522.33	52.89	5.88	4.70	2.35	0.94	0.71	1.18
Melanocyte - light, donor2	11351-117H1	803.26	76.44	11.60	10.24	4.78	6.14	0.00	2.05
Melanocyte - light, donor3	11423-118G1	316.54	40.76	12.14	6.07	3.47	1.73	0.00	2.60
Melanocyte, donor1 (MC+1)	12641-134G4	366.73	72.26	14.68	5.00	1.87	1.98	0.31	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	277.01	80.41	8.07	6.72	0.54	0.54	0.27	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	208.12	21.96	4.02	3.21	1.34	0.80	0.27	0.54
Meningeal Cells, donor1	11493-119E8	880.33	159.29	6.82	3.23	1.36	0.50	0.74	0.87
Meningeal Cells, donor2	11573-120E7	528.62	110.04	3.96	0.44	1.76	1.32	0.88	0.88
Meningeal Cells, donor3	11654-122E7	455.19	85.01	5.05	2.85	1.63	0.90	1.30	1.06
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	288.86	40.49	0.86	0.86	0.00	0.00	0.29	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	375.56	130.72	102.95	25.46	2.11	1.21	1.51	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1184.06	201.07	35.48	9.20	1.31	0.00	1.31	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	618.76	78.49	3.92	0.00	1.31	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	301.39	53.10	7.89	0.72	2.87	0.72	1.44	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	757.49	264.29	506.13	73.27	5.51	3.81	1.06	1.48
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	656.46	219.15	243.28	47.75	4.52	3.02	2.01	4.02
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	668.93	119.11	7.69	1.98	1.54	1.10	0.66	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	519.45	106.67	5.11	0.73	4.38	3.65	1.46	3.65
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	537.08	116.21	9.62	2.46	3.48	1.84	1.23	1.43
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	452.64	110.67	36.29	8.73	1.25	0.55	0.28	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	629.70	160.21	149.80	22.68	2.97	0.37	1.86	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	427.09	236.70	142.36	23.81	2.11	0.92	1.05	1.45
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	214.25	19.88	3.26	0.89	0.00	0.30	0.59	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	312.96	46.71	32.70	4.67	2.34	2.34	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	644.24	156.90	18.57	5.76	1.28	2.56	1.28	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	342.39	61.67	5.32	1.77	1.77	0.00	0.71	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	430.00	178.57	124.78	21.58	0.63	1.56	1.25	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	343.98	57.33	13.06	3.63	0.00	1.45	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	295.94	89.10	15.38	5.04	2.65	1.06	2.39	0.27
Mesothelial Cells, donor2	12156-128G5	242.23	85.08	60.06	10.01	1.50	0.00	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	253.94	90.91	99.65	11.49	2.31	1.37	1.23	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	424.00	159.34	76.97	21.61	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	384.93	114.52	62.06	15.02	1.48	1.72	0.49	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	442.28	172.55	64.78	16.49	3.83	0.29	0.88	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	528.93	103.71	72.60	13.83	0.00	0.00	6.91	10.37
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	269.03	77.80	41.84	11.78	2.17	0.31	0.62	1.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	376.49	144.58	47.29	10.79	2.49	0.41	0.83	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	386.78	94.96	53.27	2.32	2.32	0.00	2.32	4.63
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	342.11	89.34	34.54	8.01	1.50	3.75	0.75	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	393.33	146.16	48.41	13.50	2.33	0.00	1.40	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	642.38	175.20	38.93	19.47	0.00	0.00	0.00	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	316.41	76.61	32.72	6.91	2.03	1.63	0.81	1.22
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	407.05	152.45	53.85	11.88	1.58	1.58	1.19	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	316.40	59.86	68.41	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	294.68	67.26	34.51	9.73	0.00	2.65	1.77	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	370.82	157.67	64.59	15.58	3.04	0.76	0.76	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	332.92	101.32	35.53	18.42	0.00	1.32	0.00	6.58
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	290.54	73.85	35.87	9.55	1.06	2.12	1.06	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	261.51	100.37	38.67	4.60	0.92	0.00	2.76	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	276.89	79.58	35.17	6.86	1.49	1.49	0.60	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	263.24	90.54	20.12	6.71	0.00	0.00	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	543.19	101.85	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	260.44	66.74	30.61	5.27	3.01	2.01	0.50	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	318.47	112.65	42.07	10.22	1.19	0.71	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	357.72	126.06	37.60	8.29	2.21	0.55	2.21	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	316.82	82.43	36.38	5.99	2.07	1.84	0.23	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	321.82	141.35	50.69	10.10	2.52	0.84	1.26	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	388.29	106.81	47.08	8.97	1.63	1.02	0.41	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	293.27	64.15	28.96	4.08	1.72	1.07	0.21	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	336.55	122.93	35.12	6.67	2.89	0.67	1.11	1.33
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	371.47	82.55	51.59	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	274.21	80.38	29.79	7.01	0.88	1.53	0.44	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	272.74	136.88	45.63	9.13	1.52	0.51	1.01	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	361.23	66.28	28.17	6.63	4.97	0.00	1.66	4.97
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	297.61	60.88	23.10	4.35	1.09	0.54	1.09	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	354.37	154.98	48.82	10.88	2.06	0.00	0.29	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	275.85	94.86	34.89	5.45	5.45	0.00	0.00	11.99
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	257.10	76.89	33.64	6.73	2.88	1.44	0.96	1.44
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	347.40	138.88	37.62	7.20	3.20	1.60	2.40	4.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	282.47	93.24	35.65	2.74	0.00	1.37	1.37	8.23
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	291.84	83.60	29.53	9.01	1.00	1.00	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	215.58	188.63	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	236.47	77.46	22.42	10.19	0.00	0.00	0.00	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	242.61	70.51	27.15	6.13	2.63	0.44	0.88	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	322.27	86.08	33.11	3.31	0.00	0.00	1.10	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	318.91	55.71	33.30	5.12	0.00	0.00	1.28	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	277.17	65.45	26.53	5.21	1.74	0.74	0.25	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	304.11	86.99	43.15	8.35	0.00	1.39	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	333.69	90.60	37.57	6.63	4.42	0.00	2.21	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	274.53	70.08	18.46	2.74	1.37	1.03	0.68	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	304.14	101.53	24.94	6.13	1.75	0.00	0.44	1.75
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	248.92	53.97	22.73	7.46	1.42	0.36	0.36	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	274.94	81.92	27.49	5.05	2.24	1.12	0.56	1.68
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	307.98	111.80	35.33	5.82	1.66	0.00	0.00	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	244.75	57.69	22.73	5.83	1.17	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	222.33	69.38	22.62	6.94	1.51	1.21	0.90	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	321.39	110.19	31.72	7.10	2.50	0.00	1.25	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	209.35	79.41	7.22	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	203.18	43.41	18.47	3.69	0.00	1.85	0.00	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	320.98	100.73	39.27	5.69	1.71	0.57	1.71	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	244.44	48.50	23.63	4.28	1.24	0.69	0.14	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	199.29	54.16	20.47	3.89	1.04	1.30	0.78	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	262.96	88.80	23.16	3.43	0.43	0.86	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	174.68	34.94	10.80	5.72	0.64	0.00	0.00	3.81
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	149.19	41.37	15.21	2.14	1.07	0.53	0.27	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	345.13	94.59	18.86	3.59	1.20	0.90	0.90	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	182.08	26.70	15.11	3.11	1.27	0.00	0.42	0.71
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	167.54	49.37	10.51	2.87	1.27	2.55	0.32	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	272.65	85.36	19.24	3.10	1.33	0.44	0.22	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	213.87	37.54	16.68	1.90	0.00	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	159.10	43.18	13.64	1.70	0.57	0.28	0.85	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	315.61	99.06	26.79	3.93	1.97	1.97	0.98	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	196.15	24.76	7.82	1.30	1.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	205.23	37.64	7.06	1.18	0.88	0.29	0.59	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	310.24	85.34	8.65	1.73	0.86	0.00	0.58	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	300.45	55.23	4.53	1.24	0.82	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	280.51	43.48	3.87	0.30	0.60	0.00	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	116.77	30.14	0.00	0.00	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	110.50	16.04	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	165.27	24.64	3.29	0.66	1.31	0.66	0.66	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	290.34	96.78	24.19	6.31	6.31	3.16	2.10	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	248.69	88.56	4.94	2.17	1.38	0.40	0.99	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	446.10	116.42	22.35	3.73	3.73	0.93	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	235.83	52.95	7.14	1.13	1.13	1.13	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	386.73	121.72	42.88	10.12	2.13	1.60	1.33	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	220.55	37.89	1.13	0.34	0.45	0.23	0.45	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	169.45	44.94	8.10	0.00	2.21	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	152.07	26.75	2.93	0.37	1.10	0.37	0.37	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	252.01	90.22	9.33	3.11	6.22	4.67	1.56	9.33
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	28.33	9.09	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	154.56	23.18	19.32	0.00	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	132.30	19.19	3.03	0.00	3.03	1.01	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	91.50	28.25	7.59	3.79	1.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	170.24	0.00	1.36	0.00	0.00	0.00	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	15.26	2.54	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	12.15	0.81	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	36.25	6.04	0.00	0.00	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	1244.82	11.42	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	1011.36	39.15	3.26	0.00	6.52	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	446.73	52.28	19.01	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	552.16	12.55	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	653.63	366.67	332.85	48.47	3.23	1.51	3.23	2.15
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	755.70	353.29	400.32	78.39	5.75	4.70	3.66	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	250.98	78.10	26.70	10.01	1.33	0.00	0.67	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	245.00	61.77	45.91	11.27	0.83	0.42	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	481.06	74.16	15.78	6.85	3.61	0.38	1.33	1.14
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	588.87	105.33	15.96	11.17	0.00	0.00	0.00	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	195.82	56.44	11.56	0.68	0.68	0.00	1.36	2.04
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	211.33	16.54	5.51	0.00	0.00	1.84	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	226.85	59.43	25.53	8.37	2.93	0.42	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	329.13	75.31	28.82	12.32	1.86	0.23	1.16	2.09
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	264.82	92.15	37.02	12.43	3.24	0.54	1.35	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	356.98	58.45	14.93	5.05	1.26	0.42	1.26	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	267.23	11.13	0.00	0.00	0.00	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	349.43	114.16	24.82	6.45	4.96	0.50	0.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	296.11	51.97	15.16	7.04	1.89	1.08	0.81	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	269.98	87.50	39.44	10.65	2.72	0.68	1.13	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	284.96	92.10	50.62	18.94	1.96	0.65	0.82	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	354.85	81.65	30.25	8.38	3.83	0.36	1.09	1.28
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	292.80	94.95	29.70	9.02	2.65	0.00	1.06	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	267.14	91.25	57.03	17.41	2.40	0.00	3.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	354.43	57.10	14.11	6.56	3.94	0.66	0.98	2.30
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	270.28	103.75	106.84	28.46	3.09	0.16	1.46	1.14
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	331.07	106.89	49.03	13.05	1.06	0.88	0.88	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	239.10	97.05	55.56	9.14	2.81	0.00	1.41	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	298.81	108.03	61.14	15.63	0.92	0.92	0.92	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	300.14	110.54	81.30	19.92	3.53	0.64	0.96	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	406.28	85.88	46.56	16.90	6.21	3.10	2.76	4.14
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	245.26	15.17	37.93	2.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	311.01	97.58	51.69	12.25	0.89	0.67	0.45	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	234.56	82.56	47.42	11.85	3.39	1.27	1.27	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	356.74	76.43	40.82	11.16	1.66	0.71	1.19	1.66
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	352.41	136.07	194.02	47.65	5.58	0.43	3.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	153.47	54.17	27.08	9.03	0.00	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	295.57	110.30	104.96	23.33	2.00	1.00	1.67	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	214.61	145.18	104.60	21.19	0.90	0.00	0.90	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	211.89	117.45	90.87	13.89	4.76	0.79	0.40	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	234.95	116.08	50.15	18.57	1.86	0.00	2.79	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	338.64	100.27	86.65	29.89	4.16	0.76	0.38	1.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	277.33	120.58	168.48	38.78	4.89	0.65	1.30	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	200.46	45.76	40.96	11.33	1.31	0.87	0.44	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	269.56	193.58	190.87	31.21	1.81	0.90	0.90	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	246.93	134.05	123.47	21.17	5.29	0.88	1.76	2.65
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	251.31	111.69	31.25	10.64	2.66	0.66	1.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	298.12	103.18	96.73	26.29	2.98	0.50	0.99	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	207.87	93.41	138.20	28.71	3.06	0.00	1.91	1.91
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	457.90	74.40	25.41	11.19	1.21	2.12	0.91	1.81
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	330.43	154.50	167.76	23.65	3.98	0.66	1.11	1.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	223.63	105.04	88.77	13.55	3.39	0.68	2.71	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	219.71	15.33	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	273.14	85.36	84.14	21.34	2.44	0.00	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	230.07	89.07	123.38	27.07	1.89	0.00	0.63	2.52
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	199.45	29.66	13.92	4.84	2.42	0.91	0.61	3.93
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	277.69	240.51	393.99	47.47	7.91	0.79	2.37	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	331.02	56.68	38.54	13.60	4.53	1.13	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	177.03	15.17	0.00	5.06	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	416.91	94.91	18.88	5.71	3.85	1.24	1.99	0.62
Myoblast, donor2	11322-117D8	541.23	95.51	5.37	2.49	4.60	4.03	2.49	1.53
Myoblast, donor3	11398-118D3	711.66	148.49	15.64	8.41	1.68	1.35	1.85	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	615.40	30.65	4.96	7.15	1.90	0.73	1.31	1.02
Natural Killer Cells, donor1	11230-116C6	1008.66	149.15	6.15	14.45	4.31	1.23	1.85	0.92
Natural Killer Cells, donor2	11311-117C6	923.06	167.97	16.59	26.24	9.95	4.52	2.41	1.21
Natural Killer Cells, donor3	11387-118C1	906.65	116.87	14.17	16.20	3.87	2.58	2.39	1.66
Neural stem cells, donor1	11275-116H6	389.80	121.95	32.30	6.90	1.45	1.45	1.81	0.36
Neural stem cells, donor2	11352-117H2	275.37	21.18	15.41	3.85	0.00	0.00	1.93	1.93
Neurons, donor1	11494-119E9	192.30	61.45	39.83	7.97	1.14	1.14	0.00	0.00
Neurons, donor2	11574-120E8	190.88	49.10	13.21	4.40	0.22	0.66	0.00	0.00
Neurons, donor3	11655-122E8	152.10	39.46	21.38	4.93	2.47	0.00	0.00	0.82
Neutrophils, donor1	11233-116C9	303.46	108.58	2.78	6.50	1.86	0.93	1.86	0.00
Neutrophils, donor2	11314-117C9	278.29	101.46	0.00	0.00	5.80	11.60	2.90	2.90
Neutrophils, donor3	11390-118C4	453.25	164.93	10.38	2.44	2.44	0.61	0.61	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	309.42	33.25	3.80	1.31	1.66	0.12	0.12	1.07
Nucleus Pulposus Cell, donor2	11409-118E5	224.67	46.56	2.93	0.65	1.63	1.30	0.98	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	341.54	54.15	5.41	2.41	2.21	0.80	0.40	0.40
Olfactory epithelial cells, donor1	11933-125I7	423.83	340.55	502.29	83.14	8.81	3.99	2.75	3.99
Olfactory epithelial cells, donor2	11934-125I8	535.27	282.69	261.99	50.81	9.84	7.24	3.18	6.22
Olfactory epithelial cells, donor3	11935-125I9	519.51	243.01	241.77	50.28	4.99	1.59	2.84	2.04
Olfactory epithelial cells, donor4	11936-126A1	522.93	532.96	559.64	73.53	5.75	2.24	2.24	2.24
Oligodendrocyte - precursors, donor1	11496-119F2	310.54	163.69	120.97	18.66	0.60	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	583.42	231.41	133.36	33.61	3.19	1.49	0.21	0.85
Osteoblast - differentiated, donor2	11353-117H3	254.91	59.44	61.73	11.43	10.29	2.29	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	176.28	35.38	25.45	8.07	1.86	1.24	0.62	0.62
Osteoblast, donor1	11277-116H8	923.44	352.18	277.52	85.02	3.91	1.37	2.35	1.37
Osteoblast, donor2	11354-117H4	680.55	208.59	207.18	56.19	0.70	1.40	0.70	0.70
Osteoblast, donor3	11426-118G4	762.11	224.65	279.21	57.41	6.40	2.13	2.31	2.84
Pancreatic stromal cells, donor1	11249-116E7	614.25	115.74	33.19	15.08	3.37	1.60	1.18	1.85
Pericytes, donor1	11491-119E6	555.89	88.90	9.46	4.23	1.34	0.11	0.33	0.56
Pericytes, donor2	11571-120E5	324.61	45.27	6.34	1.13	1.81	0.45	1.13	0.68
Pericytes, donor3	11652-122E5	721.03	250.45	56.97	14.24	3.26	3.66	1.83	3.05
Perineurial Cells, donor1	11499-119F5	477.40	123.65	18.87	4.52	1.13	0.34	0.79	1.02
Perineurial Cells, donor2	11579-120F4	375.77	53.37	3.13	1.20	1.20	0.37	0.46	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	660.43	164.15	10.20	5.10	1.27	0.32	0.32	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	429.98	93.54	2.20	5.14	4.90	1.96	1.47	2.20
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	669.73	138.09	14.75	17.08	2.98	1.94	1.29	1.29
Placental Epithelial Cells, donor1	11278-116H9	303.98	57.64	5.74	1.43	1.20	0.48	0.48	0.24
Placental Epithelial Cells, donor2	11355-117H5	372.59	53.23	29.94	5.54	3.33	2.22	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	351.43	56.74	16.88	7.46	2.55	1.37	1.57	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	226.58	63.92	37.97	5.70	3.16	1.90	2.22	0.95
Preadipocyte - breast, donor1	11467-119B9	538.19	139.00	31.14	9.94	2.63	1.50	1.69	1.31
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	2338.27	998.53	411.16	95.55	7.05	4.83	4.83	1.17
Preadipocyte - breast, donor2	11328-117E5	823.14	249.69	135.54	30.17	11.26	7.20	4.28	3.38
Preadipocyte - omental, donor1	11468-119C1	593.64	135.97	43.26	9.27	3.09	2.02	0.96	0.75
Preadipocyte - omental, donor2	11329-117E6	635.94	278.90	174.59	39.28	1.75	1.31	0.87	3.06
Preadipocyte - omental, donor3	11403-118D8	551.51	250.26	334.20	43.12	7.88	4.58	2.15	4.58
Preadipocyte - perirenal, donor1	11469-119C2	518.71	158.47	89.57	4.92	4.92	1.97	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	784.69	173.83	82.61	30.40	3.07	1.23	0.92	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	436.50	79.68	18.95	6.73	1.42	4.07	0.53	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	444.95	68.11	41.21	15.16	2.89	1.02	0.51	0.51
Preadipocyte - visceral, donor1	11280-116I2	443.10	72.38	19.19	6.80	1.02	0.28	1.02	1.02
Preadipocyte - visceral, donor2	11357-117H7	346.98	40.04	6.44	5.06	1.84	2.30	0.46	0.92
Preadipocyte - visceral, donor3	11429-118G7	364.46	62.69	17.66	5.64	1.67	1.99	0.63	0.73
Prostate Epithelial Cells (polarized), donor1	11253-116F2	158.55	39.37	5.73	2.26	1.66	0.75	0.30	0.30
Prostate Epithelial Cells, donor2	11331-117E8	322.56	115.24	11.51	2.57	5.28	3.93	2.17	1.76
Prostate Epithelial Cells, donor3	11404-118D9	161.48	37.78	5.08	2.02	1.10	0.73	0.24	0.43
Prostate Stromal Cells, donor1	11254-116F3	538.52	177.91	98.64	22.44	2.85	1.94	1.48	1.03
Prostate Stromal Cells, donor2	11332-117E9	531.98	124.61	81.94	14.52	4.66	3.23	2.33	2.33
Prostate Stromal Cells, donor3	11405-118E1	482.48	123.57	99.69	22.84	7.61	2.29	1.77	2.09
Renal Cortical Epithelial Cells, donor1	11516-119H4	651.13	243.44	45.99	7.30	1.09	0.36	0.73	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	292.29	193.66	23.01	5.82	1.11	0.69	1.04	0.83
Renal Epithelial Cells, donor1	11517-119H5	924.17	400.71	114.63	20.80	2.54	0.51	0.51	1.52
Renal Epithelial Cells, donor2	11597-120H4	618.14	225.49	72.55	13.52	5.69	0.71	2.13	1.42
Renal Epithelial Cells, donor3	11678-122H4	312.41	193.20	33.45	6.99	0.53	1.06	1.06	0.95
Renal Glomerular Endothelial Cells, donor1	11514-119H2	557.62	103.49	10.21	1.36	4.77	0.68	0.00	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	435.42	94.33	6.87	1.48	1.62	0.54	0.67	1.08
Renal Glomerular Endothelial Cells, donor3	11675-122H1	467.33	115.45	29.31	4.88	4.00	1.33	0.89	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	400.60	99.15	20.63	4.66	1.33	2.00	0.00	1.33
Renal Mesangial Cells, donor1	11518-119H6	866.05	293.38	136.23	18.71	1.76	1.10	0.88	0.88
Renal Mesangial Cells, donor2	11598-120H5	641.41	294.68	163.02	27.59	4.39	1.25	3.13	1.88
Renal Mesangial Cells, donor3	11679-122H5	629.45	337.89	205.28	34.95	4.44	1.66	2.77	2.22
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	476.72	121.60	8.86	5.91	1.61	0.54	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	319.22	85.18	12.23	1.27	1.27	1.27	0.84	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	486.94	263.81	37.61	8.68	3.09	1.74	1.93	1.74
Retinal Pigment Epithelial Cells, donor0	11215-116A9	222.98	47.19	1.30	0.26	1.56	0.52	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	623.63	145.25	27.29	7.96	2.56	1.99	1.99	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	465.16	154.37	11.32	2.06	5.15	2.06	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	381.38	85.56	22.58	5.27	1.25	0.50	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	134.30	57.06	43.03	12.43	0.53	0.13	0.00	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	494.95	50.92	24.12	13.40	1.79	0.00	1.79	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	312.06	29.17	13.21	7.71	3.85	2.20	0.00	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	406.62	28.42	9.86	5.80	1.16	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	876.89	135.62	78.02	19.89	2.08	1.04	1.04	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	684.12	139.92	83.22	31.48	4.67	1.99	1.79	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	867.77	163.29	55.66	34.02	2.90	1.23	0.56	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	947.32	174.16	116.72	30.64	3.10	3.10	1.86	2.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	746.35	158.85	98.48	39.86	5.59	1.86	2.56	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	800.87	147.92	62.87	25.19	4.85	2.31	1.16	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	801.19	160.18	92.55	24.78	2.60	1.23	0.96	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	710.53	152.94	94.85	36.76	4.69	3.33	2.87	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	842.91	171.13	62.36	37.99	1.43	0.54	1.97	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	837.79	168.70	100.85	30.99	2.44	0.86	1.00	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	728.66	149.81	92.61	36.06	3.22	2.90	1.07	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	721.34	145.82	70.59	34.74	2.66	2.88	1.55	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	853.03	167.28	93.29	19.88	3.25	1.34	0.19	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	743.81	154.18	94.37	38.94	4.10	0.93	1.40	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	815.89	186.03	56.94	28.75	2.07	1.32	0.38	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	852.77	144.52	92.50	28.27	2.39	0.40	1.86	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	738.72	132.87	89.07	37.48	3.11	1.46	1.85	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	734.81	138.25	60.92	28.45	3.25	3.06	1.53	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	860.76	147.48	95.05	27.87	1.07	1.28	0.75	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	767.20	144.36	102.03	35.60	7.57	3.36	2.80	7.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	776.05	155.35	76.39	35.55	3.59	0.51	1.03	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	796.05	153.52	97.00	27.53	3.28	0.18	0.91	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	751.12	143.60	100.56	37.03	3.92	2.82	1.10	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	839.37	148.69	70.38	31.16	4.16	2.42	1.75	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	831.92	202.61	118.64	29.01	4.01	2.59	0.24	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	701.39	144.84	94.05	33.53	4.17	3.37	1.39	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	854.47	180.76	78.34	33.67	3.51	2.10	2.10	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	853.47	169.62	116.53	28.41	3.32	1.04	0.00	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	864.49	168.34	106.40	37.61	9.95	3.54	1.99	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	744.88	162.93	72.27	35.30	3.34	1.25	2.51	1.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	849.77	184.78	122.20	34.59	3.10	1.21	1.21	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	744.02	130.62	98.94	38.83	2.04	0.34	0.85	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	705.24	154.24	82.13	29.30	3.66	1.54	2.12	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	883.24	210.28	123.62	30.43	4.81	2.58	1.20	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	775.55	131.68	98.76	38.54	3.98	1.23	1.51	3.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	757.97	152.51	85.04	32.51	6.57	1.48	1.15	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	834.94	151.68	74.99	20.11	3.24	0.34	1.19	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	670.40	118.66	78.27	34.92	1.33	2.66	0.59	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	730.08	145.27	69.84	28.52	2.67	0.80	1.33	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	569.38	46.60	13.27	4.84	1.24	0.83	0.41	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	607.40	76.43	20.24	14.76	2.38	1.43	0.71	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	695.92	102.38	32.25	16.93	1.61	0.20	1.01	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	721.85	87.21	21.85	11.11	1.79	3.01	0.85	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	660.99	67.43	15.72	14.67	4.19	3.84	1.75	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	581.76	55.00	15.72	10.58	1.51	0.60	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	751.82	110.39	38.43	16.89	1.84	1.84	0.37	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	1052.64	110.18	30.42	23.14	3.49	1.31	1.31	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	860.32	82.14	31.64	17.04	4.26	1.22	1.22	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	745.06	109.71	40.09	12.06	2.71	0.60	1.81	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	902.49	69.67	26.46	19.90	2.71	3.85	2.04	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	830.63	74.29	30.55	17.67	3.00	2.10	2.40	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	840.22	61.52	23.97	10.51	2.72	2.48	0.71	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	846.95	64.89	30.52	20.06	10.89	4.70	1.92	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	798.70	72.12	27.64	25.24	9.62	2.40	3.61	1.20
Schwann Cells, donor1	11498-119F4	848.76	142.93	7.52	2.44	3.57	1.32	1.32	1.13
Schwann Cells, donor2	11578-120F3	326.63	37.43	0.00	0.00	0.00	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	426.55	76.68	5.26	1.97	2.63	1.75	1.10	0.88
Sebocyte, donor1	11220-116B5	538.46	149.54	24.10	6.03	2.19	0.00	2.19	0.55
Sebocyte, donor2	11301-117B5	306.52	125.00	50.09	8.27	6.43	4.60	1.38	2.76
Sebocyte, donor3	11378-118B1	228.37	68.22	29.89	8.86	2.47	1.44	0.62	0.82
Sertoli Cells, donor1	11255-116F4	710.68	203.76	195.48	39.76	4.97	6.63	3.31	1.66
Sertoli Cells, donor2	11333-117F1	511.21	282.44	285.26	36.72	11.30	8.47	0.00	5.65
Skeletal Muscle Cells, donor1	11281-116I3	415.87	50.94	12.93	4.93	1.06	0.09	0.62	0.88
Skeletal Muscle Cells, donor2	11358-117H8	272.51	13.01	1.45	4.34	0.72	1.45	1.45	0.72
Skeletal Muscle Cells, donor3	11430-118G8	1120.29	223.22	34.28	10.03	11.70	0.84	1.67	1.67
Skeletal Muscle Cells, donor4	11451-119A2	316.70	61.42	3.46	0.47	2.98	1.10	1.57	0.16
Skeletal Muscle Cells, donor5	11455-119A6	303.38	66.44	4.31	1.49	2.68	1.49	0.59	0.45
Skeletal Muscle Cells, donor6	11459-119B1	355.82	79.11	5.54	1.08	2.62	0.92	0.62	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	495.20	87.83	4.54	2.77	1.76	1.13	0.88	0.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	451.61	104.16	4.14	2.00	3.85	1.57	1.28	1.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	395.35	81.05	7.54	2.08	2.38	0.79	0.79	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	411.32	139.02	59.73	16.77	1.52	1.01	0.59	0.76
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	810.62	131.00	17.37	7.24	2.90	2.90	0.00	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	512.97	84.21	13.21	3.16	4.82	3.30	1.38	0.69
Skin - palm, donor1	10286-104F7	239.06	34.92	59.09	21.49	0.00	0.00	2.69	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	180.34	107.11	5.19	0.72	1.87	0.00	0.43	1.30
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	778.63	515.27	17.99	1.64	12.27	0.82	0.00	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	224.86	102.82	5.32	1.43	2.21	0.00	0.52	0.78
Small Airway Epithelial Cells, donor1	11256-116F5	369.90	103.00	5.28	0.97	2.92	1.39	2.36	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	288.07	105.07	6.61	1.97	2.25	0.70	1.55	1.41
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	929.30	510.85	16.92	5.71	1.90	1.06	1.69	1.48
Small Airway Epithelial Cells, donor3	11406-118E2	241.72	56.96	9.07	3.22	2.55	1.50	1.35	0.82
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	278.65	65.73	34.87	4.94	2.78	0.93	0.62	2.47
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	746.59	356.84	104.05	12.23	3.33	2.45	3.11	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	550.79	108.16	36.45	18.81	3.53	0.00	1.18	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	351.16	73.81	24.31	5.75	2.65	0.88	1.55	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	602.48	167.75	33.08	11.03	0.39	0.39	2.36	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	601.06	122.84	38.63	23.95	0.77	0.00	3.09	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	213.16	26.02	2.00	0.00	4.00	2.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	629.99	250.59	152.64	44.45	2.26	1.60	2.53	1.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	336.25	106.17	71.37	17.51	4.21	1.77	1.33	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	226.23	70.29	52.75	9.47	3.71	0.13	1.54	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	320.71	74.23	7.16	1.63	0.65	0.98	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	443.28	191.96	137.92	23.33	0.89	0.59	1.18	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	346.80	181.94	166.71	23.21	3.42	1.00	1.57	1.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	886.58	290.05	117.94	17.73	2.93	1.46	1.14	0.98
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	467.30	80.07	26.18	4.26	1.52	1.22	1.52	2.13
Smooth Muscle Cells - Carotid, donor1	11285-116I7	772.59	79.30	7.83	5.05	2.27	2.02	0.00	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	257.07	73.45	12.24	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	500.20	143.05	107.29	22.41	4.77	2.38	1.91	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	402.46	162.81	48.52	12.24	0.88	1.92	0.44	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	356.65	144.64	45.20	9.04	4.30	1.51	0.43	2.58
Smooth Muscle Cells - Colonic, donor3	11396-118D1	413.74	109.47	26.34	6.93	3.99	1.05	1.57	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	569.84	158.08	40.84	13.61	2.01	1.24	2.47	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	495.82	129.35	43.12	16.17	2.16	4.31	3.23	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	447.09	90.85	35.86	9.86	6.57	2.99	0.90	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	965.48	287.80	96.27	17.07	3.41	1.37	2.39	1.71
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	459.40	139.31	17.75	4.63	1.18	1.18	0.94	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	267.20	108.89	18.52	4.63	2.31	2.42	0.91	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	203.66	48.01	14.34	4.10	0.46	0.68	0.00	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	573.62	137.67	59.17	10.87	7.85	3.02	4.23	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	288.50	57.75	3.44	1.06	1.32	0.53	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	660.34	163.25	82.29	17.31	2.00	1.86	1.46	1.60
Smooth Muscle Cells - Prostate, donor2	11335-117F3	396.82	73.63	14.15	4.13	3.88	3.26	0.50	2.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	496.42	89.54	47.94	14.46	1.78	1.78	1.52	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	576.41	125.29	9.50	4.07	1.66	0.90	0.75	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	498.11	58.51	8.25	3.75	6.00	0.75	1.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	379.91	117.59	312.72	5.17	19.38	0.00	0.00	12.92
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	840.85	199.52	44.65	18.60	8.37	0.93	3.72	4.19
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	378.66	86.33	39.38	11.11	1.51	2.52	1.01	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	357.27	76.15	36.04	10.03	2.82	4.70	1.57	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	437.48	69.62	9.44	4.13	1.47	0.59	0.59	1.18
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	304.15	36.24	4.08	2.17	0.58	0.17	0.42	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	314.87	42.04	11.21	2.34	1.40	0.93	0.00	4.20
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	551.49	285.82	266.68	82.75	2.16	1.15	3.17	1.15
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	627.70	250.11	211.10	57.11	10.20	4.33	3.31	2.04
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	615.24	160.96	70.70	18.99	4.32	1.50	0.75	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	593.21	111.10	24.18	4.19	0.56	0.84	0.56	0.98
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	619.53	264.94	232.43	32.43	1.42	0.75	1.84	1.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	355.23	83.81	16.19	4.76	1.90	1.43	0.95	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	549.02	260.08	253.47	69.24	1.47	1.96	1.96	2.45
Smooth Muscle Cells - Uterine, donor1	11258-116F7	527.18	186.70	237.52	26.29	1.99	2.43	1.33	2.43
Smooth Muscle Cells - Uterine, donor3	11466-119B8	605.05	69.34	18.73	3.80	3.80	1.76	1.17	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	312.34	55.20	12.44	3.30	1.55	0.58	0.58	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	435.29	101.55	46.81	11.11	3.44	3.70	2.64	3.44
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	217.96	63.60	12.27	2.23	4.46	1.49	0.37	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	438.75	131.88	68.63	5.75	4.31	1.44	2.87	3.95
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	504.49	104.76	35.20	6.81	3.97	1.70	3.12	2.84
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	576.23	143.76	94.13	20.48	3.94	0.39	1.18	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	250.90	39.62	17.52	2.54	2.03	1.78	0.76	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	249.97	47.52	34.34	7.99	1.60	1.20	0.00	2.80
Smooth muscle cells - airway, control, donor3	11968-126D6	365.75	95.31	61.03	10.87	7.11	2.51	1.67	2.09
Smooth muscle cells - airway, control, donor4	11969-126D7	393.73	51.34	13.29	4.13	0.92	1.83	0.00	2.75
Synoviocyte, donor1	11291-117A4	501.76	645.68	1098.97	126.41	5.22	5.05	3.70	4.88
Synoviocyte, donor2	11368-117I9	245.57	26.32	7.21	2.85	1.84	0.67	0.34	0.84
Synoviocyte, donor3	11440-118H9	239.50	46.92	21.45	4.69	1.12	1.12	0.67	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	866.89	119.35	2.14	1.43	2.50	0.71	0.00	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	501.46	65.41	0.00	5.95	0.00	0.00	1.98	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	622.86	137.77	4.40	2.32	1.62	0.69	1.16	1.85
Tracheal Epithelial Cells, donor1	11292-117A5	377.92	112.54	3.58	2.01	0.65	0.43	0.93	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	411.69	111.33	6.96	1.93	1.16	1.55	0.77	1.55
Tracheal Epithelial Cells, donor3	11441-118I1	432.36	116.25	4.58	1.72	2.29	3.44	2.29	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	143.32	49.82	44.90	15.01	0.62	0.49	0.12	0.25
Urethra, donor2	10319-105A4	366.88	401.05	1204.95	178.04	3.60	0.00	5.40	7.19
Urothelial Cells, donor1	11520-119H8	668.93	305.78	9.03	1.06	4.25	1.59	1.86	0.80
Urothelial Cells, donor2	11600-120H7	369.32	171.84	9.21	2.80	1.60	0.80	2.40	1.60
Urothelial Cells, donor3	11681-122H7	406.84	184.05	5.96	1.15	2.06	0.46	0.69	1.60
Urothelial cells, donor0	11216-116B1	414.14	118.36	3.57	1.34	1.34	0.67	1.34	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	826.61	323.88	42.71	10.68	1.78	0.00	0.00	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	816.31	315.94	40.03	14.30	4.29	2.86	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	477.79	204.67	34.91	10.95	2.05	1.37	0.68	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	547.84	185.25	13.43	9.30	1.03	0.34	1.38	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	525.83	192.32	12.20	6.39	2.32	1.16	2.91	1.74
Whole blood (ribopure), donor090612, donation1	12182-129A4	749.69	283.22	30.20	9.37	1.04	1.04	0.00	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	781.04	295.53	35.79	13.77	1.84	0.92	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	494.79	246.48	33.78	20.08	0.00	4.56	0.00	4.56
Wilms' tumor cell line:G-401	10809-111A8	232.78	59.71	23.93	5.80	1.60	0.74	0.99	0.25
Wilms' tumor cell line:HFWT	10597-108E3	98.56	17.60	14.08	4.40	0.00	0.00	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	155.30	24.02	3.07	1.68	0.00	0.28	0.84	0.00
achilles tendon, donor2	10292-104G4	287.25	78.53	43.40	8.27	2.07	4.13	0.00	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	148.13	12.24	1.02	0.51	0.51	1.02	0.00	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	85.90	4.18	0.00	0.00	0.00	0.00	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	165.95	10.09	0.00	0.00	0.95	0.47	0.12	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	299.60	44.08	0.00	0.00	2.18	0.27	0.54	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	187.20	30.64	0.84	0.56	0.84	0.00	0.28	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	232.63	69.37	2.75	1.48	1.06	0.63	0.63	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	373.20	86.02	1.91	1.63	2.72	1.63	1.36	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	68.30	4.41	0.44	0.44	0.44	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	280.95	15.93	0.82	0.82	0.82	0.41	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	512.17	38.05	1.55	1.94	2.72	0.39	0.78	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	168.54	11.22	0.00	0.00	0.92	0.37	0.18	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	370.55	42.91	3.90	0.00	0.00	0.00	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	106.90	12.08	3.25	2.32	0.46	0.23	0.46	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	169.32	28.48	0.52	0.26	1.04	0.52	1.04	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	228.24	31.56	0.00	0.00	0.58	1.17	0.58	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	207.75	19.52	1.86	0.93	0.93	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	356.56	21.80	4.52	1.65	4.52	0.00	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	0.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	233.43	22.27	0.00	0.00	2.23	0.00	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	99.73	14.34	1.00	0.33	1.00	0.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	96.63	7.43	0.00	0.00	3.72	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	344.64	115.26	0.00	0.00	1.88	0.75	0.38	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	490.21	60.62	1.74	0.00	3.93	0.00	1.31	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	425.50	144.33	15.00	1.87	0.00	0.00	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	44.27	7.06	25.20	16.72	0.00	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	383.45	146.59	109.20	30.56	1.09	0.93	0.00	0.62
adipose, donor1	10184-103D4	371.20	69.78	4.69	0.00	1.76	3.52	1.76	0.00
adipose, donor2	10185-103D5	175.59	34.06	6.08	1.62	0.81	1.22	0.41	1.22
adipose, donor3	10186-103D6	233.62	70.52	8.17	1.09	1.91	0.82	0.00	0.54
adipose, donor4	10187-103D7	182.02	132.61	20.80	2.60	1.73	0.87	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	196.33	44.82	12.15	7.89	1.42	0.47	0.79	0.47
adrenal gland, adult, pool1	10081-102A9	87.30	29.10	36.38	7.28	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	958.79	182.90	0.40	0.13	2.00	0.67	1.20	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	369.81	53.59	5.00	3.22	1.43	0.36	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	300.25	88.80	2.55	1.62	0.70	0.00	0.46	1.39
amniotic membrane cells, donor2	12236-129G4	214.02	44.29	11.83	7.78	0.34	0.34	0.34	1.01
amniotic membrane cells, donor3	12237-129G5	426.88	110.18	2.65	0.59	1.47	1.18	0.88	0.59
amygdala - adult, donor10196	10167-103B5	33.20	5.93	2.37	2.37	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	55.36	8.52	2.84	1.42	1.01	0.20	0.61	0.61
amygdala, newborn, donor10223	10360-105E9	60.03	12.27	23.24	1.94	0.00	0.32	0.65	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	998.65	96.13	16.04	10.06	4.33	0.51	0.76	0.89
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	206.94	27.58	4.85	3.75	0.22	0.44	0.66	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	235.50	18.71	12.03	8.35	0.67	1.34	0.67	0.33
aorta, adult, pool1	10052-101G7	844.55	772.37	1967.80	465.42	16.67	8.63	5.10	8.63
appendix, adult	10189-103D9	206.87	164.56	502.61	115.27	4.27	1.55	1.55	3.49
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	1.72	0.34	0.00	0.00	0.00	0.00	0.00	0.00
artery, adult	10190-103E1	177.99	135.87	341.03	95.11	0.00	4.08	2.72	8.15
astrocytoma cell line:TM-31	10425-106D2	1105.34	124.59	52.01	18.11	2.75	1.30	1.01	1.01
b cell line:RPMI1788	10427-106D4	80.15	8.77	0.89	0.89	0.15	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	533.53	372.06	503.01	76.02	7.77	4.44	5.27	3.33
bile duct carcinoma cell line:HuCCT1	10432-106D9	914.32	112.53	8.34	8.73	1.69	0.69	2.28	1.09
bile duct carcinoma cell line:TFK-1	10496-107C1	155.83	13.56	1.00	1.84	0.50	0.17	0.50	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	167.21	14.54	0.00	0.00	2.24	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	542.77	767.44	2621.40	398.60	11.84	5.98	5.76	13.15
blood, adult, pool1	10053-101G8	458.43	150.59	19.93	4.43	2.21	2.21	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	614.86	126.74	67.65	30.83	1.71	0.86	0.86	0.86
bone marrow, adult	10192-103E3	334.71	76.26	16.20	2.02	2.70	0.67	0.67	0.67
brain, adult, donor1	10084-102B3	29.73	15.38	8.20	3.08	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	46.44	10.13	11.58	3.01	0.33	0.00	0.33	0.11
brain, fetal, pool1	10085-102B4	109.53	8.01	8.01	5.34	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	250.42	108.03	49.55	17.18	3.96	2.31	0.00	2.31
breast carcinoma cell line:MDA-MB-453	10419-106C5	646.46	127.82	67.90	56.30	0.87	0.62	0.75	1.25
breast, adult, donor1	10080-102A8	165.42	85.86	110.49	34.09	1.89	0.00	0.00	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	105.70	12.70	1.78	1.02	0.76	0.25	0.25	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	281.39	14.84	1.24	1.55	1.55	0.00	0.62	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	238.51	12.89	5.06	2.30	3.22	0.46	0.92	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	50.84	7.02	6.05	5.57	0.97	0.00	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	45.61	2.82	1.41	2.35	0.00	0.94	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	278.70	12.69	5.14	3.50	1.75	0.33	0.66	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	157.81	33.59	4.12	0.32	1.27	0.32	0.00	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	129.36	24.49	64.68	13.58	1.60	0.00	0.53	0.27
caudate nucleus - adult, donor10196	10177-103C6	82.90	5.76	1.15	0.00	1.15	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	48.19	5.19	2.84	1.00	0.33	0.00	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	46.61	6.88	2.29	0.76	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	81.67	10.62	5.86	2.20	0.73	0.00	0.00	0.73
cerebellum - adult, donor10196	10173-103C2	40.79	2.91	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	54.02	4.06	4.27	1.07	1.28	0.43	0.00	0.00
cerebellum, adult, pool1	10083-102B2	17.94	6.90	5.52	2.07	0.69	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	83.03	7.47	0.00	0.83	0.83	0.00	0.83	0.83
cerebral meninges, adult	10188-103D8	60.26	30.76	38.58	18.41	1.51	0.50	0.00	0.50
cerebrospinal fluid, donor2	10294-104G6	93.55	36.54	6.58	2.19	1.46	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	138.46	11.79	3.45	3.45	0.29	0.14	0.29	0.14
cervical cancer cell line:ME-180	10553-107I4	468.98	106.89	109.21	47.73	1.66	0.50	0.50	0.17
cervix, adult, pool1	10013-101C4	540.70	512.98	970.11	198.22	5.56	2.20	0.42	2.73
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	1393.52	108.27	54.34	18.81	4.60	2.65	4.88	2.09
chondrosarcoma cell line:SW 1353	10700-109G7	514.66	97.97	95.36	15.68	1.31	0.00	2.61	2.61
choriocarcinoma cell line:BeWo	10423-106C9	291.55	76.43	5.10	3.11	1.24	0.50	0.25	0.37
choriocarcinoma cell line:SCH	10785-110H2	98.45	40.78	0.37	0.12	0.37	0.25	0.00	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	112.90	13.28	0.24	0.00	1.19	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	193.75	41.60	3.70	1.99	0.57	0.57	0.85	0.85
chorionic membrane cells, donor2	12239-129G7	445.85	212.88	232.97	45.74	4.28	1.79	1.19	1.39
chorionic membrane cells, donor3	12240-129G8	235.73	31.87	8.24	1.10	1.65	1.65	1.10	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	104.01	13.13	0.00	0.00	1.01	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	216.11	30.35	1.73	1.34	0.77	0.58	0.19	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	276.65	31.89	1.06	1.06	1.06	0.00	0.84	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	170.77	15.66	0.26	0.00	0.77	0.77	0.26	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	200.76	13.30	0.48	0.48	0.48	0.00	0.97	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	239.24	19.75	1.22	0.41	0.81	1.02	0.20	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	219.07	33.27	0.29	1.18	1.77	0.29	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	261.67	30.75	1.04	0.78	0.00	0.26	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	373.73	64.46	0.00	0.00	5.94	3.66	2.06	2.06
clear cell carcinoma cell line:TEN	10636-108I6	286.29	25.68	18.91	7.63	1.74	0.87	0.35	0.35
colon carcinoma cell line:CACO-2	10513-107D9	157.60	66.63	23.43	7.50	0.18	0.73	0.18	0.55
colon carcinoma cell line:COLO-320	10420-106C6	191.18	38.77	1.52	1.52	0.00	0.38	0.38	0.00
colon, adult, donor1	10082-102B1	179.69	474.82	1677.94	274.90	9.52	5.95	1.19	7.14
colon, adult, pool1	10014-101C5	249.34	317.14	984.91	187.77	3.41	0.71	0.82	1.65
colon, fetal, donor1	10070-101I7	99.50	183.54	867.66	127.92	4.33	1.85	2.47	1.85
common myeloid progenitor CMP, donor1	12130-128D6	169.59	18.33	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	284.71	96.03	42.07	8.07	0.85	0.00	1.27	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	258.24	97.20	54.94	10.26	0.91	0.15	0.30	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	299.93	102.09	59.79	10.43	1.41	0.85	0.28	0.28
corpus callosum, adult, pool1	10042-101F6	105.92	24.54	19.02	5.31	0.33	0.11	0.22	0.22
cruciate ligament, donor2	10295-104G7	340.40	144.26	259.35	51.87	2.43	3.24	0.81	4.05
diaphragm, fetal, donor1	10069-101I6	102.73	32.10	15.25	4.82	0.00	0.80	3.21	0.80
diencephalon, adult	10193-103E4	27.12	2.88	1.68	0.24	0.00	0.24	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	169.68	16.30	0.23	0.23	1.61	0.69	0.46	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	290.29	21.28	4.62	2.82	2.56	0.00	0.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	133.84	14.20	0.72	0.24	0.48	0.24	0.00	0.48
ductus deferens, adult	10196-103E7	187.38	254.15	999.17	122.59	5.48	1.50	1.99	3.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	115.22	187.23	390.30	60.49	5.76	2.88	2.88	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	217.02	171.41	509.07	65.47	7.36	4.41	2.94	4.41
dura mater, adult, donor1	10041-101F5	463.89	166.50	143.54	32.21	1.24	0.50	0.99	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	88.61	17.54	1.55	0.67	0.22	0.00	0.44	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	165.50	48.00	4.16	1.29	0.57	0.29	0.72	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	336.67	30.83	3.70	3.08	0.62	0.00	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	242.47	15.14	4.84	1.82	1.82	0.61	0.00	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	284.36	29.33	6.48	2.78	0.62	0.00	0.00	1.54
embryonic pancreas cell line:2C6	10603-108E9	346.75	22.33	3.94	1.31	1.31	0.00	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	166.59	44.25	6.70	2.01	1.34	0.34	0.00	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	465.59	60.90	18.30	7.97	1.99	2.17	2.17	1.27
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	219.99	46.96	7.24	3.54	2.25	0.80	0.48	0.80
epidermoid carcinoma cell line:A431	10426-106D3	246.66	37.57	5.00	3.78	1.00	0.00	0.11	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	580.17	75.56	19.03	10.56	0.77	0.44	1.32	0.88
epididymis, adult	10197-103E8	189.01	164.52	524.95	95.45	5.86	4.60	2.30	3.77
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	371.50	48.79	1.77	1.60	0.89	1.24	0.53	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	130.56	30.28	8.65	3.15	0.00	0.39	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	298.27	44.82	4.32	2.88	1.83	0.52	0.52	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	298.51	29.92	3.35	2.17	1.08	0.89	0.59	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	293.07	36.41	2.91	1.79	1.23	1.79	0.45	0.67
esophagus, adult, pool1	10015-101C6	309.40	363.34	1277.00	206.83	6.90	2.34	0.74	4.88
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	181.72	56.36	23.54	5.89	0.63	0.13	0.88	0.63
eye - muscle inferior rectus, donor1	10272-104E2	154.53	43.46	55.54	7.24	0.00	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	96.79	46.29	21.04	6.31	0.00	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	120.55	23.81	22.32	1.49	0.00	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	137.58	37.83	33.25	3.44	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	144.28	52.47	34.98	11.66	0.00	0.00	2.91	2.91
eye, fetal, donor1	10054-101G9	114.15	36.36	85.17	19.07	1.02	0.25	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	337.87	60.91	9.62	2.56	1.41	0.90	0.64	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	202.76	8.55	0.00	0.71	0.47	0.47	0.71	0.47
frontal lobe, adult, pool1	10040-101F4	36.12	9.38	10.51	3.57	0.19	0.09	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	282.23	67.26	21.62	11.41	1.50	0.90	1.50	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	351.94	26.52	2.47	1.01	1.01	0.27	1.37	0.27
gall bladder, adult	10198-103E9	290.20	356.11	1209.09	196.53	7.48	5.31	2.66	3.14
gamma delta positive T cells, donor1	11937-126A2	977.08	157.30	17.72	13.96	4.29	1.61	1.61	1.61
gamma delta positive T cells, donor2	11938-126A3	984.52	197.95	17.18	21.66	4.86	2.99	0.75	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	669.13	132.22	4.86	4.65	8.66	3.38	1.90	3.17
gastric adenocarcinoma cell line:MKN45	10612-108F9	5.61	0.58	8.12	8.32	0.19	0.00	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	76.24	8.36	2.62	0.82	0.66	0.00	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	172.98	19.22	10.07	1.83	0.00	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	16.45	0.69	0.23	0.46	0.69	0.23	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	308.88	23.41	0.11	0.11	0.92	0.69	0.69	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	385.59	37.37	0.70	0.70	0.84	0.00	0.42	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	149.65	20.45	6.73	2.74	1.25	0.75	0.00	1.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	518.47	165.82	7.71	4.86	1.58	0.74	0.63	1.37
glioblastoma cell line:A172, tech_rep2	10444-106F3	459.37	153.36	9.69	6.74	2.11	0.84	1.83	1.12
glioblastoma cell line:T98G	10485-107A8	667.98	50.77	16.00	8.50	1.77	0.66	0.88	0.44
glioma cell line:GI-1	10413-106B8	286.43	43.64	80.54	23.14	0.59	0.88	0.59	0.29
globus pallidus - adult, donor10196	10175-103C4	49.57	9.48	3.64	0.00	0.73	0.00	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	69.81	10.50	4.39	1.95	0.49	0.00	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	82.15	10.95	2.74	0.00	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	78.87	17.59	2.66	0.00	0.00	0.00	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	408.67	51.39	0.00	0.00	0.00	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	262.28	21.86	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	182.93	31.36	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	446.39	202.56	200.64	27.84	2.88	0.64	3.20	4.16
hIPS +CCl2, biol_rep1	14383-156B9	166.66	140.03	3.21	0.92	0.00	0.46	0.46	1.38
hIPS +CCl2, biol_rep2	14384-156C1	167.36	135.81	4.57	0.00	0.46	0.00	0.00	0.91
hIPS +CCl2, biol_rep3	14385-156C2	205.47	115.94	6.44	1.29	1.29	0.64	0.64	0.00
hIPS, biol_rep1	14380-156B6	347.82	186.85	1.44	0.00	2.87	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	184.50	107.68	3.43	0.00	0.69	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	54.07	25.38	3.31	0.00	2.21	0.00	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	310.04	245.39	44.54	7.18	2.30	2.01	1.72	0.29
heart - mitral valve, adult	10205-103F7	221.83	64.58	91.19	22.72	1.20	0.60	0.60	2.09
heart - pulmonic valve, adult	10206-103F8	268.01	324.75	820.25	176.50	2.88	1.57	1.31	2.61
heart - tricuspid valve, adult	10207-103F9	284.76	75.77	55.79	15.82	0.00	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	100.19	26.53	23.06	6.53	1.22	0.82	0.00	0.61
heart, adult, diseased, donor1	10051-101G6	150.74	42.58	42.16	8.09	0.85	0.43	0.43	0.00
heart, adult, pool1	10016-101C7	133.16	46.00	60.94	14.26	0.23	0.00	0.23	0.69
heart, fetal, pool1	10046-101G1	225.07	48.46	33.99	9.75	0.62	0.31	0.21	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	375.78	272.12	607.79	92.25	3.09	0.93	1.54	3.09
hepatoblastoma cell line:HuH-6	10633-108I3	159.35	24.97	0.00	0.00	0.00	0.00	0.00	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	109.17	50.05	14.92	2.76	0.66	0.66	0.22	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	108.63	44.91	12.99	3.16	0.73	0.36	0.61	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	112.27	49.52	14.35	2.63	0.71	0.20	0.20	0.20
hepatoma cell line:Li-7	10484-107A7	477.12	45.49	3.67	2.22	0.89	0.78	0.56	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	199.59	74.67	6.73	3.92	0.60	0.00	0.40	0.30
hippocampus - adult, donor10196	10169-103B7	46.37	4.73	3.79	1.89	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	69.80	11.63	3.67	2.65	0.20	0.20	0.41	0.20
hippocampus, adult, donor10258	10374-105G5	36.35	2.99	1.00	0.00	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	59.22	9.87	2.47	1.76	1.06	0.35	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	214.84	151.37	1.22	0.00	6.71	2.44	2.44	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	199.69	194.78	1.57	0.20	1.77	1.18	0.59	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	212.51	204.64	2.03	0.51	2.54	3.05	1.52	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	272.35	51.31	2.82	0.56	1.13	0.00	0.56	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	262.08	60.42	1.55	1.03	8.00	2.32	1.03	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	308.24	74.40	3.80	0.38	2.66	1.52	0.76	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	390.05	76.49	2.34	0.29	3.80	2.04	1.46	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	333.27	71.95	1.94	0.86	4.31	2.15	1.72	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	377.87	70.07	3.75	1.25	0.83	0.42	0.42	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	241.77	70.56	16.34	0.95	1.18	0.47	0.47	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	309.06	99.16	19.29	3.21	4.02	0.48	1.13	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	259.89	78.10	15.49	2.69	1.35	1.35	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	177.45	267.59	5.63	0.63	4.07	1.72	0.63	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	169.99	229.43	4.91	0.98	3.93	1.97	4.91	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	134.40	245.24	3.49	0.87	5.24	3.49	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	344.78	103.66	9.16	1.72	3.44	0.76	0.95	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	343.19	92.01	9.16	1.31	0.44	0.87	0.87	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	315.35	93.96	8.00	1.00	2.50	1.00	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	226.26	58.21	4.14	0.94	2.26	1.32	1.13	1.70
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	213.72	58.20	3.64	0.91	4.09	0.00	0.91	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	209.87	46.05	2.82	0.31	2.51	0.31	0.63	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	245.28	116.76	15.84	1.63	3.76	0.82	1.31	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	269.99	113.80	15.68	1.74	3.77	0.87	0.87	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	255.88	103.43	13.45	1.79	2.69	0.00	0.90	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	201.93	252.73	3.33	0.92	3.51	1.48	0.92	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	216.25	246.20	5.14	0.86	3.71	0.29	0.57	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	259.28	286.63	2.04	0.82	3.67	1.22	1.63	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	365.46	118.30	24.65	2.82	5.63	3.52	2.11	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	314.21	114.03	18.05	2.53	4.12	1.27	0.95	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	334.70	113.48	18.46	3.33	2.12	1.21	1.21	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	308.72	64.64	5.69	0.00	3.62	0.00	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	302.20	65.75	7.97	0.00	0.66	0.00	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	312.20	60.29	4.62	1.80	3.08	0.00	1.54	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	326.97	129.10	27.10	5.62	4.60	2.05	1.79	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	344.54	113.58	17.42	2.27	5.30	0.00	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	294.05	153.58	25.88	5.38	4.03	0.67	1.68	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	234.26	222.67	3.14	0.97	4.11	1.93	1.69	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	181.38	217.93	4.46	0.45	3.57	0.89	0.89	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	233.66	241.47	4.88	0.98	5.85	1.95	1.46	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	398.83	110.63	9.47	2.44	4.89	1.53	2.14	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	562.81	100.85	0.00	0.00	0.00	3.25	6.51	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	383.56	106.23	6.62	1.32	4.96	0.66	1.32	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	380.37	78.81	4.93	0.55	3.83	2.19	0.55	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	336.19	68.76	2.17	1.09	3.98	0.36	1.09	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	298.58	69.39	1.78	0.36	3.20	0.36	0.00	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	250.61	134.85	14.32	4.77	5.97	3.58	1.19	4.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	413.72	179.98	20.04	2.98	3.39	1.08	1.22	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	263.74	127.96	18.59	2.69	1.35	0.81	1.35	0.54
immature langerhans cells, donor1	11904-125F5	339.97	35.35	3.87	2.66	0.24	0.00	0.97	0.24
immature langerhans cells, donor2	11905-125F6	198.83	38.02	40.40	16.63	0.00	0.00	2.38	0.00
insula, adult, pool1	10039-101F3	51.29	14.10	14.38	5.68	0.19	0.00	0.00	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	26.66	3.25	11.06	5.53	0.00	0.33	0.00	0.00
kidney, adult, pool1	10017-101C8	162.81	55.37	67.09	16.22	1.10	0.40	0.10	0.30
kidney, fetal, pool1	10045-101F9	298.72	68.40	23.41	6.22	1.06	0.21	0.35	0.64
large cell lung carcinoma cell line:IA-LM	10509-107D5	602.31	39.77	0.14	0.00	2.13	0.43	1.28	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	115.71	7.60	1.11	0.14	0.83	0.41	0.41	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	394.16	58.35	19.45	7.89	0.92	0.00	0.92	0.55
left atrium, adult, donor1	10079-102A7	102.43	53.40	122.59	29.42	1.09	0.00	0.54	0.54
left ventricle, adult, donor1	10078-102A6	73.83	23.26	24.27	4.55	0.00	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	552.14	375.12	93.57	27.09	4.38	0.27	1.92	1.37
leiomyoma cell line:10964C	10569-108B2	331.59	55.68	8.62	2.16	8.62	2.87	2.16	1.08
leiomyoma cell line:15242A	10570-108B3	276.63	68.48	22.83	1.09	5.43	1.09	4.35	1.63
leiomyoma cell line:15425	10571-108B4	344.80	68.23	21.37	5.58	5.34	4.37	0.97	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	323.82	126.99	63.49	12.70	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	325.17	58.55	40.78	19.87	4.18	1.05	4.18	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	346.26	63.16	6.14	4.13	1.06	0.59	1.06	0.12
liposarcoma cell line:KMLS-1	10782-110G8	371.78	48.58	12.34	5.47	2.50	1.72	0.78	0.94
liposarcoma cell line:SW 872	10726-110A6	664.51	29.24	7.80	5.24	3.17	1.34	1.10	0.97
liver, adult, pool1	10018-101C9	53.97	10.21	8.91	2.92	0.16	0.32	0.16	0.00
liver, fetal, pool1	10086-102B5	49.86	28.22	8.47	2.82	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	51.48	12.54	2.04	1.02	0.73	0.15	0.00	0.29
locus coeruleus, adult, donor10252	10165-103B3	38.94	4.24	2.21	0.55	0.37	0.18	0.18	0.00
locus coeruleus, adult, donor10258	10375-105G6	42.88	9.03	1.69	1.41	1.69	0.00	0.56	0.00
locus coeruleus, newborn, donor10223	10362-105F2	80.34	18.09	2.94	0.42	0.84	0.00	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	375.47	64.35	5.40	2.77	1.52	0.00	0.28	0.83
lung adenocarcinoma cell line:PC-14	10408-106B3	219.23	13.10	5.52	3.45	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	363.68	14.50	7.91	4.35	1.85	0.53	2.24	2.77
lung, adult, pool1	10019-101D1	327.45	113.17	124.39	34.02	1.54	1.18	0.59	1.30
lung, fetal, donor1	10068-101I5	276.85	107.88	100.46	12.84	0.57	2.00	0.86	0.57
lung, right lower lobe, adult, donor1	10075-102A3	226.36	95.77	81.56	21.54	1.37	1.37	1.37	1.83
lymph node, adult, donor1	10077-102A5	176.09	57.75	39.29	8.99	0.95	0.47	0.95	1.42
lymphangiectasia cell line:DS-1	10727-110A7	233.86	18.85	3.51	1.32	1.53	0.00	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	88.44	1.81	1.21	0.75	0.45	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	363.58	14.44	0.85	0.85	1.70	0.00	2.55	0.00
mature adipocyte, donor1	12231-129F8	372.51	46.62	3.55	1.78	0.44	0.44	1.33	0.44
mature adipocyte, donor2	12232-129F9	384.76	42.96	3.11	0.83	2.08	0.00	0.83	0.00
mature adipocyte, donor3	12233-129G1	381.67	40.54	3.08	3.08	0.95	0.24	0.47	0.47
mature adipocyte, donor4	12234-129G2	244.00	31.06	2.11	1.32	1.05	0.00	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	81.01	4.29	1.91	1.67	0.48	0.00	0.00	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	30.46	5.64	1.13	0.00	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	36.60	2.76	2.76	1.66	0.00	0.18	0.37	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	19.38	1.91	0.95	0.95	0.00	0.00	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	59.71	3.84	1.71	1.28	0.00	0.00	0.85	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	30.71	6.41	2.03	1.52	0.17	0.17	0.00	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	46.26	4.24	4.46	0.85	0.64	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	67.42	1.93	1.93	0.00	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	56.35	8.61	3.23	1.44	0.00	0.00	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	80.47	12.98	8.44	0.65	0.65	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	85.92	14.55	10.99	3.56	0.77	0.31	0.15	0.00
medulla oblongata, adult, pool1	10038-101F2	132.56	46.28	52.24	13.31	0.24	0.41	0.41	0.08
medulla oblongata, newborn, donor10223	10361-105F1	143.73	18.05	6.25	0.35	0.35	0.69	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	499.73	75.72	30.11	8.86	2.21	0.22	0.66	1.55
medulloblastoma cell line:ONS-76	10759-110E3	377.82	39.49	1.96	1.10	0.86	0.24	0.49	0.73
melanoma cell line:COLO 679	10514-107E1	191.90	7.33	0.00	0.14	0.72	0.43	0.29	0.00
melanoma cell line:G-361	10465-106H6	277.43	7.87	1.36	0.81	1.63	0.54	0.81	0.81
meningioma cell line:HKBMM	10691-109F7	513.59	49.39	2.35	1.63	7.96	2.89	2.53	1.45
merkel cell carcinoma cell line:MKL-1	10843-111E6	46.70	2.64	4.41	6.17	0.88	1.76	0.00	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	84.25	7.26	1.81	2.59	0.52	0.26	0.52	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	488.69	69.35	19.49	6.44	2.76	1.69	1.53	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	586.61	137.79	68.89	17.27	3.09	2.36	1.82	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	518.04	87.38	13.67	1.66	3.31	3.73	1.24	2.48
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	389.40	44.39	25.99	6.18	0.56	0.28	0.84	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	395.15	92.63	47.76	12.90	1.35	1.93	1.54	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	305.39	40.26	6.25	2.08	2.78	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	282.17	24.20	3.43	1.89	1.72	0.86	1.37	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	536.32	89.02	11.73	4.03	2.30	2.42	1.38	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	420.86	58.76	10.48	2.25	2.65	0.93	0.66	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	384.19	54.56	14.04	3.92	1.35	1.89	0.54	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	431.62	104.56	52.78	11.38	1.99	2.13	1.28	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	259.86	26.35	10.87	1.32	0.66	0.33	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	596.24	105.58	77.90	14.94	2.49	1.38	1.25	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	463.93	94.60	39.45	12.22	1.40	2.79	1.40	2.79
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	457.74	132.91	70.44	15.92	3.06	1.84	1.22	1.63
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	443.93	193.39	200.58	29.12	5.75	3.24	1.80	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	498.52	167.49	160.35	20.48	2.07	1.45	1.03	1.14
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	305.51	156.17	98.26	10.03	5.24	1.60	4.10	1.37
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	415.36	110.76	52.44	4.20	2.94	0.84	2.52	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	487.32	96.24	128.67	21.37	3.74	1.79	1.49	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	439.58	85.60	35.80	9.63	1.75	1.23	1.58	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	471.61	114.50	177.82	27.61	2.58	1.10	1.84	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	497.34	245.52	315.63	43.50	6.87	6.30	4.29	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	755.72	109.46	41.68	10.10	12.21	3.79	3.79	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	673.59	176.73	75.81	15.07	5.48	2.28	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	589.07	175.72	72.64	14.07	3.58	3.33	2.30	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	620.36	191.08	81.93	16.49	4.71	1.83	1.83	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	570.58	179.92	81.33	12.63	4.93	3.08	1.85	2.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	548.14	178.63	72.49	12.00	6.35	3.29	2.12	2.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	588.58	191.23	73.11	15.23	6.09	3.38	1.69	1.69
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	561.56	167.01	69.95	16.11	3.93	2.75	1.96	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	483.31	178.87	63.02	12.05	6.95	3.71	2.32	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	483.04	193.21	0.00	0.00	0.00	0.00	0.00	48.30
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	723.93	200.16	79.89	20.48	5.19	3.75	1.73	2.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	632.49	200.57	69.61	16.51	4.02	2.01	1.78	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	615.78	205.50	76.43	18.03	4.33	1.92	2.64	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	541.93	200.93	86.53	27.13	2.93	0.00	0.73	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	543.09	181.93	68.14	11.08	5.03	3.02	2.01	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	539.97	178.49	72.87	8.19	2.87	2.46	1.64	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	583.34	199.31	70.02	18.90	3.44	2.58	1.29	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	732.82	281.64	76.56	16.41	2.73	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	614.63	211.76	51.65	10.33	10.33	0.00	15.49	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	692.44	204.62	68.21	11.37	14.29	5.20	3.25	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	600.91	219.70	65.47	14.55	10.18	7.27	2.91	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	672.21	222.83	84.23	16.53	7.46	5.33	3.73	5.33
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	538.09	170.91	71.96	16.36	13.08	3.27	1.64	4.91
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	630.50	207.58	74.63	17.10	9.72	3.11	5.05	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	495.30	207.77	86.05	18.89	8.39	10.49	4.20	6.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	578.20	219.56	68.55	10.93	8.94	4.97	4.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	629.27	181.15	42.90	4.77	9.53	0.00	14.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	569.84	185.01	68.19	14.82	5.34	4.15	2.96	2.96
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	616.54	221.76	76.76	14.62	9.75	2.44	0.00	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	892.73	189.37	54.10	0.00	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	658.08	222.95	67.14	13.30	7.60	2.53	5.07	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	568.06	171.42	66.22	16.90	4.48	2.07	2.07	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	466.38	189.13	60.18	2.15	12.90	6.45	4.30	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	375.23	187.61	51.89	15.97	0.00	3.99	0.00	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	275.51	48.21	27.55	10.33	3.44	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	270.15	45.23	23.23	4.48	0.81	0.41	0.41	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	277.26	48.46	32.57	7.15	5.56	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	134.41	16.51	2.36	1.18	2.36	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	154.61	16.83	2.81	1.87	0.94	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	160.40	12.03	1.34	0.00	1.34	1.34	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	156.11	37.85	14.19	0.00	0.00	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	174.62	35.95	10.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	189.31	31.67	5.51	3.44	4.13	0.00	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	88.08	19.79	15.34	1.48	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	76.26	16.82	16.82	3.36	1.12	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	76.96	27.99	14.63	3.82	1.27	0.64	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	48.36	14.91	29.42	2.42	0.40	0.00	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	52.33	6.54	21.81	0.00	0.00	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	67.15	20.27	29.14	5.07	2.53	2.53	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	29.74	15.17	38.84	3.64	0.61	0.00	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	13.56	45.19	0.00	0.00	4.52	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	28.83	8.24	40.36	5.77	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	117.47	39.88	44.84	6.35	0.20	0.20	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	143.75	44.13	55.49	6.81	1.95	0.32	0.65	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	158.91	61.12	59.08	15.28	3.06	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	401.56	446.43	217.41	54.16	0.00	0.77	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	768.97	67.57	7.80	3.54	3.31	0.47	2.60	1.89
mesothelioma cell line:ACC-MESO-4	10494-107B8	297.93	27.34	5.79	2.09	0.93	0.46	0.23	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	384.62	115.39	0.00	0.00	0.00	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	328.08	70.49	6.58	2.67	1.75	0.72	1.03	0.41
mesothelioma cell line:Mero-25	10850-111F4	482.50	90.33	137.99	23.38	3.18	3.63	2.04	1.36
mesothelioma cell line:Mero-41	10851-111F5	1157.10	376.74	199.00	44.49	7.82	6.60	5.13	3.18
mesothelioma cell line:Mero-48a	10852-111F6	785.64	80.82	15.72	6.20	3.54	1.33	2.44	1.77
mesothelioma cell line:Mero-82	10853-111F7	478.57	44.94	2.63	1.05	2.37	1.84	1.58	0.53
mesothelioma cell line:Mero-83	10854-111F8	588.28	156.77	5.96	1.36	3.06	0.85	1.02	0.34
mesothelioma cell line:Mero-84	10855-111F9	419.86	52.83	9.86	3.79	2.27	2.02	1.01	1.77
mesothelioma cell line:Mero-95	10856-111G1	370.61	51.35	9.73	4.97	2.69	0.62	0.21	1.24
mesothelioma cell line:NCI-H2052	10847-111F1	559.89	97.57	5.63	3.81	1.99	1.66	0.83	1.16
mesothelioma cell line:NCI-H226	10846-111E9	278.37	19.55	2.35	0.72	1.81	0.54	1.45	1.27
mesothelioma cell line:NCI-H2452	10848-111F2	405.87	28.53	2.73	1.37	1.20	0.68	0.51	0.51
mesothelioma cell line:NCI-H28	10845-111E8	623.70	164.13	1.02	3.05	5.34	3.31	3.05	2.04
mesothelioma cell line:No36	10857-111G2	399.27	86.77	46.32	18.59	2.28	1.30	0.98	0.98
mesothelioma cell line:ONE58	10858-111G3	485.28	54.46	8.94	3.25	3.79	0.81	1.35	0.81
migratory langerhans cells, donor1	11901-125F2	839.09	278.48	80.80	49.13	4.80	0.96	1.73	1.15
migratory langerhans cells, donor2	11902-125F3	1004.40	327.51	162.90	71.56	4.52	1.10	1.59	0.98
migratory langerhans cells, donor3	11903-125F4	724.56	176.79	50.43	23.69	3.05	0.90	1.08	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	308.20	15.67	35.26	15.67	8.49	5.55	4.57	3.92
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	383.18	10.17	7.63	1.70	4.87	1.48	1.06	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	528.21	63.12	14.97	10.83	2.07	0.46	0.69	1.38
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	698.18	152.61	0.19	0.00	5.14	0.76	1.90	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	216.95	17.19	0.00	0.00	0.92	0.74	0.37	0.00
myeloma cell line:PCM6	10474-106I6	382.68	16.01	1.19	0.20	1.58	0.59	0.40	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	519.46	212.55	100.44	39.06	2.03	0.00	1.52	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	368.55	34.91	1.18	0.98	1.18	0.20	0.39	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	226.64	57.94	19.95	4.12	0.45	0.22	0.56	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	190.98	49.49	16.03	3.31	0.74	0.51	1.25	0.07
nasal epithelial cells, donor2	12227-129F4	297.52	69.55	22.63	4.42	1.66	1.66	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	61.43	2.30	0.23	0.23	0.00	0.00	0.23	0.23
neuroblastoma cell line:NB-1	10539-107G8	257.62	31.06	3.18	0.94	1.68	0.00	0.37	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	268.46	10.33	1.05	0.84	1.69	0.42	0.42	0.42
neuroblastoma cell line:NH-12	10555-107I6	138.09	7.64	2.42	1.49	0.93	0.00	0.19	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	238.41	41.04	4.74	4.03	2.61	0.47	0.24	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	202.25	23.12	6.97	4.28	1.11	0.95	0.79	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	173.69	71.65	2.42	0.60	0.60	0.00	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	188.82	49.59	12.08	2.54	0.64	0.00	0.64	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	624.16	368.64	295.71	66.01	3.73	1.33	2.66	1.86
neutrophil PMN, donor1	12133-128D9	342.12	193.37	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	305.46	132.81	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	303.06	132.59	0.00	0.00	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	75.77	2.20	1.01	0.17	0.17	0.17	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	68.84	12.81	2.40	2.40	0.80	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	445.96	241.42	98.75	27.57	6.73	4.81	1.92	5.77
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	523.16	385.48	197.07	50.71	10.51	8.15	5.26	3.94
nucleus accumbens, adult, pool1	10037-101F1	52.49	15.94	13.40	5.16	0.47	0.00	0.28	0.00
occipital cortex - adult, donor10196	10172-103C1	41.21	0.00	2.06	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	54.21	5.64	2.15	0.27	0.00	0.00	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	60.78	7.28	1.09	1.09	0.36	0.00	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	19.68	5.77	8.66	1.57	0.00	0.00	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	59.22	7.72	1.72	1.72	0.86	0.00	0.43	0.43
occipital pole, adult, pool1	10036-101E9	43.52	8.99	8.67	4.18	0.24	0.00	0.00	0.00
olfactory region, adult	10195-103E6	52.16	22.74	26.94	5.54	0.57	0.76	0.38	0.19
optic nerve, donor1	10277-104E7	66.03	14.01	30.02	6.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	563.73	137.94	0.00	0.00	1.71	0.68	1.14	0.91
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	131.48	28.30	3.98	0.96	0.27	0.14	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	425.68	195.57	3.05	1.86	5.08	2.20	3.05	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	193.25	8.55	0.92	0.81	0.46	0.35	0.69	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	796.06	192.84	106.12	29.40	7.35	1.47	3.53	2.06
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	494.26	47.65	0.00	0.00	0.93	0.93	1.87	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	315.76	97.97	119.39	39.87	0.21	0.42	0.42	0.42
ovary, adult, pool1	10020-101D2	493.71	255.15	428.11	96.70	2.10	0.87	0.61	1.57
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	359.67	197.44	44.55	11.00	3.12	0.92	1.83	1.83
pancreas, adult, donor1	10049-101G4	40.45	13.17	12.23	2.82	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	88.89	20.97	0.84	1.12	1.12	0.00	0.84	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	457.91	21.12	2.56	2.04	3.07	1.70	1.02	1.19
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	381.67	52.16	3.31	1.99	0.99	0.17	0.66	0.66
paracentral gyrus, adult, pool1	10035-101E8	34.23	9.15	8.24	3.02	0.09	0.18	0.18	0.00
parietal cortex, adult, donor10258	10373-105G4	27.89	4.40	6.61	0.73	1.47	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	29.15	4.70	0.00	0.94	0.00	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	37.91	2.00	2.28	1.14	0.00	0.00	0.86	0.29
parietal lobe, adult, pool1	10034-101E7	41.15	14.36	11.72	4.76	0.09	0.00	0.09	0.00
parietal lobe, fetal, donor1	10072-101I9	116.38	12.61	1.94	1.94	0.97	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	72.90	12.34	1.12	1.87	1.50	0.00	0.37	0.75
parotid gland, adult	10199-103F1	75.23	52.42	57.35	19.12	0.62	0.00	0.00	0.00
penis, adult	10200-103F2	343.75	463.53	1251.47	233.64	15.04	12.35	6.45	22.56
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	144.66	13.39	3.90	3.35	1.12	0.56	0.56	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	265.46	22.87	13.99	5.54	0.87	0.44	0.44	0.87
pineal gland - adult, donor10196	10179-103C8	43.22	3.87	1.94	1.94	0.00	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	34.35	4.15	11.84	1.78	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	36.37	7.52	7.52	0.63	0.63	0.00	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	54.64	8.09	10.12	0.00	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	71.92	9.90	2.61	1.04	0.00	0.00	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	28.94	3.40	2.55	0.00	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	168.35	76.54	63.00	10.32	0.54	0.43	0.22	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	80.38	5.16	1.59	0.66	0.13	0.00	0.00	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	594.85	142.88	49.80	27.70	3.11	0.78	0.62	1.09
pons, adult, pool1	10033-101E6	37.78	11.10	15.41	4.65	0.52	0.09	0.09	0.00
postcentral gyrus, adult, pool1	10032-101E5	32.95	9.07	6.45	3.31	0.09	0.00	0.26	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	437.10	43.92	0.00	2.09	0.00	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	203.80	5.51	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	129.09	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	273.55	31.03	6.26	3.06	1.17	0.73	0.58	0.29
prostate cancer cell line:PC-3	10439-106E7	337.05	42.83	7.44	7.08	1.45	0.18	0.91	0.91
prostate, adult, pool1	10022-101D4	436.68	461.26	1152.96	204.78	4.17	2.09	1.27	2.72
putamen, adult, donor10196	10176-103C5	55.00	5.90	2.36	0.71	0.24	0.00	0.71	0.24
putamen, adult, donor10252	10152-102I8	37.25	1.96	7.84	0.00	0.00	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	170.48	63.38	2.19	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	38.66	4.59	3.14	0.00	0.48	0.00	0.00	0.00
putamen, newborn, donor10223	10365-105F5	34.48	11.24	0.00	0.75	0.00	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	282.21	91.64	1.45	1.45	0.58	0.00	0.87	1.16
rectum, fetal, donor1	10067-101I4	258.72	239.25	930.57	123.80	5.56	1.39	5.56	5.56
renal cell carcinoma cell line:OS-RC-2	10411-106B6	381.38	64.02	27.77	9.54	1.91	1.48	0.64	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	182.67	18.64	7.04	1.66	1.24	0.83	0.41	0.83
retina, adult, pool1	10030-101E3	274.94	59.94	58.05	24.55	0.89	0.80	0.30	0.70
retinoblastoma cell line:Y79	10475-106I7	105.74	9.09	0.52	1.30	0.26	0.52	0.78	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	125.28	12.05	0.00	0.12	0.49	0.00	0.37	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	225.24	34.59	2.81	1.12	1.12	1.12	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	548.69	286.47	152.33	37.13	2.27	0.00	0.76	7.58
salivary acinar cells, donor1	11771-123I7	331.32	52.12	5.18	0.97	1.62	0.49	0.49	0.16
salivary acinar cells, donor2	11772-123I8	327.15	70.77	19.28	4.68	1.38	1.79	0.41	0.83
salivary acinar cells, donor3	11773-123I9	172.80	39.72	37.07	5.30	2.65	0.66	0.66	1.99
salivary gland, adult, pool1	10093-102C3	89.22	64.06	59.48	13.15	0.57	1.14	0.00	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	201.84	10.37	0.67	0.59	0.34	0.17	0.17	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	180.44	8.46	0.82	0.82	0.47	0.00	0.35	0.47
seminal vesicle, adult	10201-103F3	157.66	187.82	721.12	84.12	17.46	7.94	3.70	23.81
serous adenocarcinoma cell line:JHOS-2	10639-108I9	429.98	54.90	36.92	11.66	4.13	0.97	0.97	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	503.52	40.76	1.51	0.50	5.03	2.26	1.76	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	695.45	82.29	2.01	1.00	4.01	4.01	1.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	151.51	188.45	94.56	13.03	0.81	0.54	0.13	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	164.47	7.63	3.76	3.32	0.22	0.00	0.22	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	49.42	10.19	18.71	10.71	0.65	0.13	0.00	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	56.75	22.70	48.23	9.93	0.71	0.00	0.00	2.13
skeletal muscle, adult, pool1	10023-101D5	103.15	47.85	57.09	21.59	0.24	0.24	0.48	0.12
skeletal muscle, fetal, donor1	10066-101I3	124.62	29.15	6.03	3.02	0.00	3.02	0.00	1.01
skin, adult, donor1	10074-102A2	135.70	27.14	61.07	40.71	0.00	0.00	6.79	6.79
skin, fetal, donor1	10065-101I2	172.96	42.92	20.83	8.21	2.52	1.89	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	74.71	3.00	3.00	4.00	0.33	0.00	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	116.94	5.67	7.25	3.78	1.26	0.00	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	58.79	22.74	1.16	0.77	0.77	0.58	0.19	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	93.13	3.30	1.98	0.82	0.16	0.00	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	126.75	6.11	0.00	0.32	0.32	0.48	0.00	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	185.45	1.31	6.10	4.36	1.31	0.00	0.22	0.22
small intestine, adult, pool1	10024-101D6	147.27	148.95	465.23	86.60	1.67	0.36	0.36	0.72
small intestine, fetal, donor1	10064-101I1	113.51	92.38	230.46	36.61	0.98	1.97	0.74	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	167.21	7.69	2.56	5.64	2.56	2.56	1.54	0.51
smooth muscle, adult, pool1	10048-101G3	697.31	1112.91	3447.79	564.47	18.35	12.41	7.24	5.94
somatostatinoma cell line:QGP-1	10781-110G7	131.06	7.77	2.95	3.22	0.27	0.00	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	58.04	12.62	12.16	3.67	0.23	0.23	0.23	0.69
spinal cord, adult, donor10252	10159-103A6	72.15	13.41	4.34	2.37	0.39	0.00	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	77.48	12.45	2.08	0.00	0.69	0.00	0.69	1.38
spinal cord, fetal, donor1	10056-101H2	151.85	28.05	17.08	4.27	0.61	0.61	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	96.89	12.40	4.13	1.38	0.92	0.46	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	725.56	265.55	197.15	51.23	6.12	1.34	1.49	3.44
spleen, adult, pool1	10025-101D7	255.73	96.92	50.99	16.74	0.66	0.33	0.44	0.55
spleen, fetal, pool1	10044-101F8	306.78	99.88	29.56	8.82	0.64	0.48	0.08	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	194.91	49.38	4.97	4.45	0.10	0.41	0.31	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	166.90	45.95	3.42	1.71	0.00	0.00	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	77.23	17.82	21.67	7.69	1.05	0.00	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	572.32	71.15	0.78	0.78	1.95	0.78	2.74	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	565.38	50.20	0.23	0.11	2.14	0.90	0.23	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	244.42	39.39	5.08	0.85	0.00	0.42	1.27	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	516.99	22.85	0.42	1.27	1.69	0.00	0.85	1.69
stomach, fetal, donor1	10062-101H8	104.66	83.30	665.35	101.46	1.07	1.07	1.07	1.07
submaxillary gland, adult	10202-103F4	106.53	63.23	78.62	24.50	1.71	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	59.61	10.18	7.48	0.83	0.21	0.00	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	45.52	6.21	4.14	0.52	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	67.83	17.66	21.20	2.12	0.00	0.00	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	351.46	82.99	14.44	5.27	1.15	0.92	0.69	0.00
temporal lobe, adult, pool1	10031-101E4	54.76	15.94	14.07	7.46	0.59	0.25	0.25	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	84.76	13.53	1.42	1.42	0.71	1.42	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	116.04	12.31	2.20	0.88	1.76	0.44	0.00	0.44
tenocyte, donor1	11763-123H8	449.64	100.54	38.40	6.98	4.54	2.79	0.35	2.79
tenocyte, donor2	11765-123I1	285.75	38.15	11.45	4.96	1.14	0.38	0.00	1.14
tenocyte, donor3	11768-123I4	348.43	64.50	15.57	4.45	1.11	0.74	1.48	1.85
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	557.47	354.54	4.76	0.85	6.12	1.53	2.55	2.04
teratocarcinoma cell line:NCR-G1	10798-110I6	370.42	139.20	16.49	4.62	3.08	1.08	1.39	1.39
teratocarcinoma cell line:PA-1	10807-111A6	232.93	143.97	4.96	1.39	1.24	0.46	0.77	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	300.36	245.52	16.50	5.33	2.16	0.76	2.03	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	544.19	212.15	1.13	0.38	1.89	0.38	0.38	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	163.59	119.64	1.96	1.53	1.20	0.11	0.44	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	177.18	71.00	0.33	0.00	1.95	1.63	0.33	0.33
testis, adult, pool1	10026-101D8	270.58	131.42	350.46	84.93	1.93	0.54	0.86	2.25
testis, adult, pool2	10096-102C6	172.77	59.99	88.41	19.40	2.71	0.45	0.90	0.45
thalamus - adult, donor10196	10168-103B6	47.47	7.73	4.42	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	59.23	8.13	3.28	0.47	0.31	0.00	0.16	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	132.41	9.24	4.62	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	38.70	9.55	4.12	0.82	0.16	0.00	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	48.90	9.78	1.73	0.00	0.00	0.58	0.00	0.00
throat, adult	10209-103G2	126.83	56.68	51.68	12.73	1.50	2.50	0.50	0.50
throat, fetal, donor1	10061-101H7	145.04	18.89	7.01	3.05	0.61	0.30	0.61	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	168.13	30.21	12.32	3.78	0.79	0.60	0.20	0.00
thymus, adult, pool1	10027-101D9	188.29	20.88	11.53	3.48	0.80	0.30	0.70	0.50
thymus, fetal, pool1	10043-101F7	168.12	28.37	48.63	4.99	0.00	0.10	0.10	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	511.37	69.94	4.39	3.06	2.66	0.40	2.13	1.86
thyroid carcinoma cell line:TCO-1	10783-110G9	807.13	81.86	26.40	12.15	2.93	1.26	4.47	0.84
thyroid, adult, pool1	10028-101E1	133.53	39.28	42.27	14.93	0.47	0.19	0.09	0.47
thyroid, fetal, donor1	10060-101H6	142.91	27.42	23.20	7.38	1.05	0.53	0.26	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	178.62	36.96	67.75	36.96	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	128.62	45.12	53.96	17.44	1.40	0.70	0.23	0.47
tongue, fetal, donor1	10059-101H5	99.31	19.70	22.86	7.88	0.79	0.39	0.39	0.00
tonsil, adult, pool1	10047-101G2	219.28	52.49	31.56	13.52	0.50	0.40	0.20	0.00
trachea, adult, pool1	10029-101E2	193.21	111.08	200.32	43.19	1.06	0.25	0.16	0.82
trachea, fetal, donor1	10058-101H4	123.49	37.32	61.55	9.23	1.15	0.77	0.00	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	450.99	145.61	68.02	21.26	3.90	0.71	2.13	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	291.18	56.64	2.03	0.71	0.71	0.10	0.41	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	786.26	68.32	6.74	3.76	2.51	0.94	1.41	0.31
tridermal teratoma cell line:HGRT	10694-109G1	665.89	173.13	45.66	7.61	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	440.10	40.89	0.51	0.25	2.12	0.51	0.93	0.42
umbilical cord, fetal, donor1	10057-101H3	208.65	187.79	580.05	77.20	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	588.84	797.35	1848.42	235.13	5.29	3.75	2.05	3.92
uterus, fetal, donor1	10055-101H1	420.29	235.49	661.41	91.12	8.19	2.05	1.54	3.07
vagina, adult	10204-103F6	237.15	176.41	433.60	120.84	1.29	1.29	0.00	0.65
vein, adult	10191-103E2	228.84	90.31	226.21	44.72	1.75	1.75	0.22	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	152.75	20.83	1.60	0.80	0.27	0.53	0.53	0.00